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TRPM4 IN CEREBRAL ARTERY SMOOTH MUSCLE CELLS 
 
Cerebral arterial tone is dependent on the depolarizing and hyperpolarizing 
currents regulating membrane potential and governing the influx of Ca2+ needed for 
smooth muscle contraction.  Several ion channels have been proposed to contribute to 
membrane depolarization, but the underlying molecular mechanisms are not fully 
understood.  In this review, we will discuss the historical and physiological significance 
of the Ca2+-activated cation channel, TRPM4, in regulating membrane potential of 
cerebral artery smooth muscle cells. As a member of the recently described transient 
receptor potential super family of ion channels, TRPM4 possesses the biophysical 
properties and upstream cellular signaling and regulatory pathways that establish it as a 
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The degree of arterial tone controlling blood flow within the microcirculation is 
dependent on the contractile state of smooth muscle cells encircling the vessel wall.  
Movement of ions across the plasma membrane determines resting membrane potential 
and myocyte contraction.  The ions channels responsible for these responses are still 
being characterized.  Depolarization of the plasma membrane triggers smooth muscle 
contraction by increasing Ca2+ influx through dihydropyridine-sensitive voltage-
dependent (L-type) Ca2+ channels. The subsequent rise in intracellular [Ca2+] initiates 
calmodulin-dependent cross-bridge cycling, leading to myocyte shortening and arterial 
constriction.  Due to the steep voltage sensitivity of L-type Ca2+ channels  (85), small 
variations in membrane potential can elicit significant changes in smooth muscle 
intracellular Ca2+ and vessel diameter  (7.5 nM mV-1  and 7.5 µm mV-1  respectively, for 
cerebral arteries) (85). Therefore, ion channels influencing resting membrane potential 
and governing the opening of L-type Ca2+ channels play an essential role in regulating 
the contractile state of vascular smooth muscle cells.  Efflux of K+ has been established 
as the major mechanism leading to membrane hyperpolarization and myocyte 
relaxation (79, 86, 148, 174), but less is known of the ion channels physiologically 
responsible for membrane depolarization in vascular smooth muscle cells. In the 
present review, we will summarize the contribution of Ca2+-activated cation channels in 
establishing the resting membrane potential of cerebral artery myocytes and discuss the 
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upstream mechanisms of channel regulation that are essential for smooth muscle cell 
contraction. 
 
SMOOTH MUSCLE MEMBRANE POTENTIAL  
K+ channels regulate arterial smooth muscle function through modulations of 
membrane excitability. Increases in K+ conductance through channels present in the 
plasma membrane lead to membrane hyperpolarization,  Four types of K+ channels 
have been identified in arterial smooth muscle: 1) Ca2+-activated K+ (KCa,) channels, 2) 
voltage-dependent K+ (KV) channels, 3) inward rectifier K
+ (KIR) channels, and 4) ATP-
sensitive K+ (KATP) channels. Each type serves a unique role in regulating resting 
membrane potential (121). KCa channels are activated by intracellular Ca
2+ and play a 
fundamental role in establishing intrinsic tone of resistance arteries (17, 117). In 
particular, large-conductance Ca2+-activated K+ (BKCa) channels are activated by highly 
localized intracellular Ca2+ release events from ryanodine receptors on the sarcoplasmic 
reticulum (78, 118). These events cause local Ca2+ concentrations to be elevated for a 
short period of time, inducing a coordinated efflux of K+ through multiple BKCa channels 
and give rise to spontaneous transient outward currents (STOCs) (78, 121).  KV 
channels are sensitive to changes in membrane potential within the physiological range 
(-40 to -60 mV) (67) and activate following membrane depolarization, suggesting they 
may play a role in limiting the extent of depolarization within smooth muscle cells (69, 
155, 188). KIR channels are activated by extracellular K
+ (44) and mediate external K+-
induced hyperpolarization and can link the metabolic demand of surrounding cells to 
changes myocyte contractility.  Strong evidence for the role of Kir channels is observed 
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in functional hyperemia, or coupling of neuronal activity to localized cerebral blood flow. 
Extracellular K+ released from astrocytic endfeet encompassing paremchymal arteries 
activates Kir channels localized smooth muscle cells, and causes a rapid and profound 
hyperpolarization and vessel dilation (49). Additionally, Kir channels are present at the 
junctions between endothelial and smooth muscle cells and contribute to the 
endothelial-dependent vasodilatation of cerebral and mesenteric arteries (96).  KATP 
channel activity is stimulated by an increasing ratio of intracellular ATP to ADP (6), and 
plays a role in sensing reductions in cytosolic ATP (123). Hypoxia-mediated vasodilation 
is attenuated by the KATP-specific blocker glibenclamide, suggesting a role of KATP 
channels in linking intracellular metabolic demand to changes in myocyte contractility 
(174).  Muscle relaxation is clearly mediated by several different K+ channels, all having 
distinct biophysical properties and clear functional niches in contributing to membrane 
hyperpolatization.  
Under normal physiological ionic gradients, the K+ equilibrium potential is 
approximately -80 mV, yet resting membrane potential is consistently reported in 
pressurized cerebral arteries to be more depolarized at around -45 mV (121). Therefore, 
K+ channel activity cannot completely determine membrane excitability. Channels 
permeable to cations (Ca2+ and Na+ influx) or anions (Cl- efflux) are present in smooth 
muscle cells, but the ions triggering membrane depolarization in smooth muscle cells 
are still unclear.  The predominant divalent cation current in smooth muscle cells are 
from voltage-dependent L-type Ca2+ channels, but these channels do not contribute to 
membrane excitability.  Even though the inhibition of L-type Ca2+ channels and blocking 
Ca2+ influx by dihydropyridine compounds causes myocyte relaxation, it does not alter 
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the resting membrane potential (86).  Dihydropyridine-insensitive (T-type) Ca2+ channels 
have been reported in some, but not all, types of arterial smooth muscle cells (1, 10, 12, 
122, 161, 176); however, due to their kinetic properties, including rapid inactivation and 
low active voltage range (-65 mV to -45 mV) (10), these channels are thought to have a 
more transient or specialized role. Thus, Ca2+ ions entering through L-type Ca2+ 
channels do not have a major role in regulation of membrane excitability preceding 
contraction.  
Cl- currents can be recorded from vascular smooth muscle cells (4, 19, 93, 137), 
but, because the molecular identities of these channels was only recently discovered 
and due to the lack of specific pharmacology the significance of these currents has 
been difficult to determine. Some Cl- channel blockers, like DIDS (4,4’-
diisothiocyanatostilbene-2,2’disulphonic acid), SITS 4,acetamino-
4’isothiocyanatostilbene-2,2’-disulphonic acid), and IAA-94 are effective in inhibiting 
pressure-induced vasoconstriction (4), but others, including 9-AC (9-anthracene 
chloride) and niflumic acid, have no effect (119).  It was later shown that many of the Cl- 
channel blockers reported to reduce myogenic response also inhibited nonselective 
cation channels (195) and L-type Ca2+ channels (33). The strongest evidence for the 
involvement of Cl- channels in smooth muscle cell regulation comes from recent reports 
examining the role of transmembrane protein 16A (TMEM16A), a Ca2+ activated Cl- 
channel (19, 26). Hyposmotic solution-induced cell swelling activated Cl- currents in 
arterial smooth muscle cells and were diminished following inhibition of TMEM16A 
channels through siRNA-mediated downregulation and channel specific blocking 
antibodies (19). Ca2+ activated Cl- currents contribute to membrane depolarization and 
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pressure-dependent vasoconstriction of cerebral arteries (19).  Additionally, the small 
molecular blocker of TMEM16A, T16Ainh-A01, reduced Ca
2+-activated Cl- currents in 
isolated myocytes and relaxed pre-constricted mouse thoracic arteries (26). These 
experiments clearly show that Cl- conductance can contribute to membrane excitability, 
but additional experiments are needed to further and more acutely elucidate the 
physiological contributions of these channels in cerebral arteries.  
The Cl- equilibrium potential (-30 mV) is slightly depolarized compared to resting 
membrane potential (-40 mV) of arterial myocytes, and due to the relatively small driving 
force the Cl- conductance may yield only a small depolarization. In contrast, the ionic 
gradient for Na+ is relatively large (ENa = +60 mV), and replacement of Na
+ with the 
non-permeable cation N-Methyl-D-glucamine (NMDG) causes myocyte 
hyperpolarization in rabbit posterior cerebral arteries (66).  In addition, swelling- or 
pressure-induced depolarization of rat cerebral artery myocytes are reported to arise 
from activation of cation channels (27, 195). These findings strongly suggest that cation 
influx, in particular, Na+ ions, is a major contributor to membrane depolarization, but 
molecular identity of the ion channels responsible was not determined. The presence of 
conventional voltage-gated Na+ channels in arterial smooth muscle cells has been a 
point of controversy.  Tetrodotoxin-sensitive Na+ currents are present in various types of 
cultured arterial myocytes (22, 103, 143, 149) and portal vein smooth muscle cells 
(162), but were not detected from cerebral arteries (63) and freshly isolated smooth 
muscle cells (103, 149). The isolation protocol used to liberate smooth muscle cells 
from arteries may influence detection of Na+ channels (14).  In one study, when the 
serine protease elastase was used to enzymattically dissociated cells from mesenteric 
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arteries, Na+ channel activity was detected, but when the cysteine protease papain was 
used Na+ currents were absent (14).  Additional experiments examining the effects of 
cell culturing and enzymes digestion on voltage-gated Na+ channels are required to 
determine the presence or contributions of this family of ion channels in the resting 
membrane potential of arterial smooth muscle cells.  
Ca2+-activated non-selective cation channels (NSCCa) have been observed in 
numerous cell types (183) , and until recent years the molecular identity and 
physiological significance of these channels were unknown. Since their first discovery 
by Hamill et al (1981), NSCCa currents have been recorded from numerous cell types, 
including; fibroblasts, mast cells, sensory neurons, cochlear outer hair cells, renal 
tubules, cardiac myocytes, and capillary endothelium (for review see (183)). The 
biophysical properties of NSCCa channels distinguish them from other channels (Figure  
1.1). NSCCa channels have a unitary conductance ranging from 18-34 pS, are selective 
for monovalent cations with a low or undetectable Ca2+ permeability (PCa/PNa = 0-0.14), 
and are activated by intracellular Ca2+ (183). Channels within this group exhibit a 
diverse range of Ca2+ sensitivities (100 nM to 100 mM) (183).  In pancreatic acini, 
NSCCa channels required 100 nM intracellular Ca
2+ for activation, but following exposure 
to Ca2+ currents rapidly inactivate (100).  Sturgess et al. (1986) showed that NSCCa 
channels are also inhibited by intracellular ATP (177). NSCCa channels until recently 
have rarely been associated with a clear physiological function in any of the 
aforementioned cell types (183).  In excitable cells, NSCCa channels were proposed to 
be a major contributor to long lasting membrane depolarization (139), but due to lack of 
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pharmacology and molecular tools at the time of this study the channel’s molecular 
nature was not resolved.    
 
TRPM4 
The discovery of the mammalian Transient Receptor Potential (TRP) superfamily 
of cation channels in 1995 provided novel insight into the molecular identity of NSCCa 
channels and the ion channels responsible for smooth muscle membrane 
depolarization.  The TRP superfamily consists of 28 gene products forming cation 
channels that respond to extracellular stimuli and mediate responses to chemical 
compounds and changes in temperature, osmolarity, light, and pressure (108). TRP 
channels are subdivided into six subfamilies: TRPA (ankyrin, 1), TRPC (canonical, 1-7), 
TRPM (melastatin, 1-8), TRPML (mucolipin, 1-3), TRPP (polycystin, 1-3), and TRPV 
(vanilloid, 1-6). Several Ca2+-permeable members of the TRPC, TRPV, TRPM, TRPP 
channels are involved in smooth muscle cell intracellular Ca2+ homeostasis and 
dynamics, including receptor-activated and mechanosensitive calcium entry (for review 
see (35, 36)).  Non-selective cation-conducting TRP channels, including TRPC3 and 
TRPC6, can conduct Na+ as well as Ca2+ and have important roles in smooth muscle 
membrane excitability in cerebral arteries (151, 194).  TRPC3 channels are involved in 
receptor-mediated membrane depolarization and constriction of arterial smooth muscle 
(152), whereas TRPC6 channels are intrinsically mechanosensitive (173) and contribute 
to pressure-dependent membrane depolarization of cerebral arteries (194). However, 
due to little, or no, ion selectivity of these channels, the downstream contribution of 
either Na+ or Ca2+ ions is still debated.  Additional work is needed to determine whether 
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Na+ influx via TRPC3 or TRPC6 initiates membrane depolarization, or if Ca2+ influx 
through these channels activate a downstream Ca2+ sensitive mechanism influencing 
membrane depolarization. One member of the TRPM subfamily of TRP channels, 
TRPM4, is present in cerebral arteries and due to its ion selectivity it has become a 
prime candidate for the regulation of membrane depolarization and smooth muscle 
contraction.   
TRPM4 and its closest relative TRPM5 have biophysical properties that differ 
from other members of the TRP channel superfamily, and are reminiscent of NSCCa 
channels (Figure  1.1). TRPM4 and TRPM5 channels do not conduct Ca2+ but are 
highly selective for monovalent cations (95).  As determined by ion substitution 
experiments in HEK 293 expression systems, TRPM4 is equally permeable for Na+ and 
K+, and to a lesser extent, Cs+ and Li+ (Na+ ≈ K+ > Cs+ > Li+) (128).  Additionally, 
replacement of extracellular Na+ with the non-permeable cation NMDG+ has little effect 
on outward currents at depolarizing potentials, but completely abolished inward currents 
at hyperpolarizing potentials, suggesting that Na+ is the major ion conducted at 
physiological membrane potentials (128).  The current-voltage (IV) relationship from 
single-channel recordings of inside-out patches in symmetrical cation solutions exhibits 
a non-rectifying conductance of ∼25 pS (95). Conventional whole-cell macroscopic 
currents recorded from TRPM4-expressing HEK 293 cells exhibit a large outward and 
smaller inward rectification (95, 128).  TRPM4 is not considered to be classically 
voltage-dependent.  Although shifts in the resting membrane potential can increase or 
decrease the total open probability of the channel, changes in voltage do not gate it, 
with channel activation being primarily dependent on intracellular Ca2+ concentrations. 
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TRPM4 has an unusual relationship with Ca2+, as Ca2+ is required to stimulate 
the channel but also leads to channel inactivation. TRPM4 channel activity is dependent 
upon a rise in intracellular Ca2+ above global resting levels. Under whole-cell conditions, 
channels are more sensitive to Ca2+ (EC50 = 400 nM) (95) compared with recordings 
from the inside-out configuration (EC50 = 200 μM) (43, 128). This difference in Ca
2+ 
sensitivity suggests the presence of a Ca2+-sensitive intracellular channel modulator 
under whole cell conditions that is lost when membrane patches are excised.  In 
addition to requiring Ca2+ for activation, TRPM4 exhibits a rapid Ca2+-dependent 
inactivation, leading to loss of current within two minutes following exposure to high 
global Ca2+ (40, 41, 43, 95, 125, 131).  The channel’s Ca2+ sensitivity may provide 
insight to regulatory mechanisms, where high Ca2+ is required for activation, but 
prolonged exposure or improper removal of Ca2+ leads to loss of channel activity.  
Ca2+ sensitivity of TRPM4 is regulated by several intracellular pathways. The 
channel contains a putative phosphatidylinositol 4, 5-bisphosphate (PIP2) binding site, 
five calmodulin binding sites, several Protein Kinase C (PKC) phosphorylation sites, and 
six possible ATP-binding sites (125, 130, 131).  PIP2 modulates channel activity by 
shifting the IV relationship resulting in an increase in TRPM4 current magnitude at 
negative holding potentials (125).  Blocking of phospholipase C (PLC) activity (125) or 
including PIP2 in the recording pipette solution (125, 202) can prevent Ca
2+-dependent 
inactivation.  Maintaining channel activity by supplementing the cells with a phospholipid 
source or inhibiting phosphoinositide 3-kinase activity suggests the involvement of Ca2+-
dependent PLC isoforms in regulating channel activity.  With five possible binding sites, 
two on the N-terminus and three on the C-terminus, the Ca2+ binding protein calmodulin 
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can directly influences the Ca2+ sensitivity of TRPM4 (131).  Overexpression of a 
truncated C-terminus mutant for TRPM4 or expression with dominant negative 
calmodulin mutants drastically decreases the amplitude of Ca2+-activated TRPM4 
currents (131). TRPM4 also contains multiple possible interaction sites for PKC, 
suggesting phosphorylation-dependent modulation of the channel. The PKC activating 
compound phorbol 12-myristate 13- acetate (PMA) increased the incidence of 
occurrence and current density of TRPM4 channels by enhancing the Ca2+ sensitivity of 
the channel (131).  Intracellular ATP inhibits TRPM4 currents with a half maximal 
inhibitory concentration (IC50) around 2-19 μM (130).  TRPM4 is also modulated by 
adenine nucleotides with the highest sensitivity to ADP and least to adenosine (ADP > 
ATP > AMP >> adenosine) (133). The nucleotide triphosphates GTP, UTP, and CTP 
have no effect at concentrations lower than 1 mM  (133).  In addition to the inhibition of 
TRPM4 by free ATP, higher concentrations (in the millimolar range) can prevent Ca2+-
dependent inactivation of the channel (131). Mutations of putative ATP binding sites on 
TRPM4 abolish this effect, indicating that prevention of Ca2+-dependent inactivation is 
associated with direct binding of ATP to the channel (131). In a similar manner, heat 
shifts the voltage-dependent activation curve for TRPM4 (Q10 = -5.6 ± 0.5 mV °C
-1) 
(181), a phenomenon also observed in other thermosensitive TRP channels (29, 38).  
Modulation of the monovalent cation conductance through TRPM4 by voltage, adenine 
nucleotides, phospholipids, and heat and dependence on intracellular Ca2+ for activation 
are consistent with NSCCa channels previously described in many cell types, suggesting 
the identity of these channels as TRPM4.  
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The pharmacology for TRPM4 is limited. The most commonly used TRPM4 
blockers include flufenamic acid, spermine, Gd3+, and sulfonylurea glibenclamide (28, 
128, 133, 186) are poorly selective.  Recently, a hydroxytricyclic derivative, 9-
phenanthrol, has been shown to inhibit TRPM4 current with no effect on its closest 
relative TRPM5 (60).   Additionally, at a concentration that nearly abolished TRPM4 
channel activity (60), 9-phenanthrol did not alter TRPC3, TRPC6, voltage-gated K+ 
Channels (Kv), large-conductance Ca
2+-activated K+ channels (BKCa), inwardly rectifying 
K+ channels (KIR), or L-type Ca
2+ channel currents (58). These data suggest that 9-
phenanthrol may be a specific inhibitor of TRPM4.  Pharmacological activators for 
TRPM4 include decavanadate (130) and the pyrazole derivative BTP2 (N-[4-3, 5-
bis(trifluromethyl)pyrazol-1-yl]-4-methyl-1,2,3-thiadiazole-5-carboxamide) (180), 
however, these agents also lack specificity.  Decavanadate interferes with ATP-
dependent inhibition of TRPM4 channel activity but can also interact with other ion 
channels, including IP3R and purinoreceptors (P2X) (104).  BTP2 increases TRPM4 
channel activity and reduces Ca2+-dependent inactivation, but can also inhibit TRPC3 
and TRPC5 channels (64).  9-phenanthrol is currently the most useful pharmacological 
tool for unmasking the functional significance of TRPM4. 
With the advancements of molecular techniques, previous observations of NSCCa 
currents now can be identified as TRPM4 channels.  Similar to the broad distribution 
reported for NSCCa channels, TRPM4 channels have been detected at high levels in the 
heart, pancreas, placenta, and prostate (for review see (62)), and with lower levels of 
TRPM4 detected in kidney, skeletal muscle, liver, intestines, thymus, and spleen (62). 
The functional significance and expression of TRPM4 have been extensively 
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characterized in four cell types.  TRPM4 regulates cytokine secretion in lymphocytes 
and insulin secretion in pancreatic β-cells (for review see (168)).  TRPM4 plays a role in 
controlling respiratory rhythmogenesis in neurons of the pre-Bötzinger complex (for 
review see (61)). Gain of function mutations within the TRPM4 gene in Purkinje fibers 
suggests it plays a role in isolated cardiac conduction disease in human heart (for 
review see (61)). Lastly, and as the focus of the current dissertation, TRPM4 is essential 






Figure 1.1. Comparison of Nonselective Ca2+-activated cation channels (NSCCa), 
recombinant human TRPM4 channels expressed in HEK 293 cells, and native TRPM4 
channels in vascular smooth muscle cells (VSMC). ATP, adenosine triphosphate; PM, 
plasma membrane; SR, sarcoplasmic reticulum; 9-phen, 9-phenanthrol; PKC, Protein 





Ca2+ Release from the Sarcoplasmic Reticulum is Required for Sustained TRPM4 
Activity in Cerebral Artery Smooth Muscle Cells 
 
INTRODUCTION 
The melastatin (M) Transient Receptor Potential (TRP) channel TRPM4  is a 
crucial mediator of pressure-induced vascular smooth muscle membrane depolarization 
and vasoconstriction (43), but regulation of the channel is poorly understood.  Single-
channel (43, 95, 127) and whole-cell patch clamp recordings (40) of TRPM4 activity in 
HEK cell expression systems and cerebral artery myocytes show that the level of 
intracellular Ca2+ required for channel activation (1-10 µM) is greater than that reported 
for average cytosolic or “global” [Ca2+] in arterial myocytes (100-300 nM) (86).  
However, TRPM4 also undergoes a fast desensitization, leading to decreased activity 
within two minutes following exposure to high global Ca2+ (40, 43, 94, 126, 132).  We 
propose that desensitization under these conditions is an artifact of prolonged exposure 
to high levels of intracellular Ca2 rather than an inherent property of the channel itself.  
To overcome this limitation and to limit disruption of native Ca2+ signaling pathways, we 
used the amphotericin B perforated patch clamp configuration to study TRPM4 activity 
in freshly isolated cerebral arterial myocytes. 
Intracellular Ca2+ in smooth muscle cells is not uniformly distributed.   Localized, 
transient elevations in intracellular Ca2+ arise from Ca2+ influx via persistent activity of L-
type Ca2+ channels (Ca2+ sparklets) (115, 165) and Ca2+ release from sarcoplasmic 
reticulum (SR) (Ca2+ sparks, puffs, and waves) (15, 77, 107, 118, 201).  Temporal and 
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spatial separation of SR Ca2+ release events result from the  proximity of the SR and 
the plasma membrane (144) and strong intrinsic cytosolic Ca2+ buffering mechanisms 
(99). This architecture allows for Ca2+-sensitive ion channels located at the plasma 
membrane to be activated by intracellular Ca2+ release events (77, 118).  For example, 
Ca2+ sparks result from Ca2+ release events from ryanodine receptors on the SR located 
close to the plasma membrane (118).  These events cause local [Ca2+] to be elevated 
for a short period of time and open multiple large-conductance Ca2+-activated K+ (BKCa) 
channels, giving rise to spontaneous transient outward currents (STOCs) (78, 118).  We 
hypothesize that TRPM4 channels may also be activated by intracellular Ca2+ signaling 
in smooth muscle cells.   
Using the amphotericin B perforated patch clamp configuration we recorded and 
characterized persistent, rapidly opening and closing cation currents from native 
vascular smooth muscle cells.  We call these events “Transient Inward Cation Currents” 
(TICCs). TICC activity was diminished in cells isolated from cerebral arteries treated 
with siRNA against TRPM4, suggesting that TICCs are formed by TRPM4 channels.  
TICC activity is reduced by inhibition of the sarco(endo)plasmic reticulum Ca2+ ATPase 
(SERCA) and blockade of inositol 1,4,5-trisphosphate receptor (IP3R)-mediated Ca
2+ 
release from the sarcoplasmic reticulum (SR). Our findings indicate that in cerebral 




MATERIAL AND METHODS 
Animals.  
Male Sprague-Dawley rats (250–350 g; Harlan) were used for these studies. 
Animals were deeply anesthetized with pentobarbital sodium (50 mg ip) and euthanized 
by exsanguination according to a protocol approved by the Institutional Animal Care and 
Use Committees (IACUC) of Colorado State University.  Brains were isolated in cold 3-
(N-morpholino) propanesulfonic acid (MOPS)-buffered saline (in mM): 3 MOPS (pH 
7.4), 145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 2 pyruvate, and 5 
glucose and 1% bovine serum albumin. Cerebral and cerebellar arteries were dissected 
from the brain, cleaned of connective tissue, and stored in MOPS-buffered saline prior 
to further manipulation. 
 
Isolated cerebral artery smooth muscle cell preparation.   
Vessels were placed in the following cell isolation solution (in mM): 60 NaCl, 80 
Na-glutamate, 5 KCl, 2 MgCl2, 10 glucose, and 10 HEPES (pH 7.2).  Arterial segments 
were initially incubated in 1.2 mg/ml papain (Worthington) and 2.0 mg/ml dithioerythritol 
for 17 min at 37°C, followed by 15 min incubation at 37°C in 1.0 mg/ml type II 
collagenase (Worthington). The digested segments were then washed three times in 
ice-cold cell isolation solution and incubated on ice for 30 min.  Following this incubation 
period, vessels were triturated to liberate smooth muscle cells and stored in ice-cold cell 





RNAi and Reverse Permeabilization.   
Small interfering RNAs (siRNA) against TRPM4 were used to down-regulate 
expression of the channel in isolated cerebral arteries.  siRNA molecules purchased 
from Qiagen (1027280 [AllStars Negative Control], SI02868292 [Rn_Trpm4_1], and 
SI02868313 [Rn_Trpm4_4]) were dissolved as instructed at a concentration of 20 μM in 
siRNA Suspension Buffer. Control siRNA or TRPM4 siRNA molecules were introduced 
into intact cerebral arteries using a reversible permeabilization procedure.  To 
permeabilize the arteries, segments were first incubated for 20 minutes at 4oC in the 
following solution (in mM): 120 KCl, 2 MgCl2, 10 EGTA, 5 Na2ATP, and 20 TES; (pH 
6.8).  Arteries were then placed in a similar solution containing siRNA (40 nM) for 3 
hours at 4oC and then transferred to a third siRNA-containing solution with elevated 
MgCl2 (10 mM) for 30 minutes at 4°C.  Permeabilization was reversed by placing 
arteries in a MOPS-buffered physiological siRNA-containing solution consisting of (in 
mM): 140 NaCl, 5 KCl, 10 MgCl2, 5 glucose, and 2 MOPS; (pH 7.1, 22
oC) for 30 minutes 
at room temperature.  Ca2+ was gradually increased in the latter solution from nominally 
Ca2+-free to 0.01, 0.1, and 1.8 mM over a 45 minute period.  Following the reversible 
permeabilization procedures, arteries were organ cultured for two to three days in D-
MEM/F-12 culture media supplemented with L-glutamine (2 mM) (Gibco), and 0.5% 
penicillin-streptomycin (Gibco).  Arteries were then used for smooth muscle cell isolation 




Real-Time RT-PCR.   
 Arteries containing siRNA were enzymatically dissociated as described above, 
and RNA was immediately isolated and purified using an RNeasy® Protect Mini Kit 
(Qiagen).  mRNA was synthesized into cDNA with the aid of an Omniscript® Reverse 
Transcriptase Kit (Qiagen) using 100ng RNA/reaction.  Down-regulation of TRPM4 was 
detected using a real-time SYBR Green detection assay (Bio-Rad), QuantiTect primers 
spanning intron/exon boundaries of TRPM4 (Qiagen), and an iQ5 Multicolor Real-Time 
PCR Detection System (Bio-Rad).  Samples were normalized to β-Actin, and cycling 
parameters were selected based on the protocol for QuantiTect primer assays (Qiagen).  
β-Actin primers were designed based on a published sequence (NM_031144), and were 
purchased from Integrated DNA Technologies, Inc. Sequences were as follows: 5’-
TTGCTGACAGGATGCAGAAGGAGA-3’ (forward) and 5’-
ACTCCTGCTTGCTGATCCACATCT-3’ (reverse).  Down-regulation of TRPM4 mRNA 
was calculated according to the Pfaffl Method (142). 
 
Immunocytochemistry. 
  Cells were enzymatically dissociated from siRNA-treated vessels as described 
above, and allowed to adhere to glass slides for 20 minutes at 4°C.  Cells were fixed 
with 4% formaldehyde for 10 minutes, permeabilized with cold methanol (-80°C), 
blocked with 2% bovine serum albumin, and incubated with primary antibodies 
overnight at 4°C. The following primary antibodies were used; rabbit anti-TRPM4 at 
1:250, (Abcam, ab63080), sheep anti-TRPC3 at 1:250, (Abcam, ab63012); and goat 
anti-TRPC6 at 1:100, (Santa Cruz, sc-19197).  Cells were subsequently washed and 
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incubated with appropriate fluorescent secondary antibody for 2 hours at room 
temperature. The following secondary antibodies were used at 1:1000; anti-rabbit 
conjugated to Texas Red, (Santa Cruz, sc-2780), anti-sheep conjugated to FITC, (Santa 
Cruz, sc-2704), and anti-goat conjugated to Texas Red, (Santa Cruz, sc-2783). 
Immunofluorescence images were obtained using a Fluoview 1000 laser scanning 
confocal microscope (Olympus) and a 60x, 1.4 numerical aperture oil immersion 
objective, with the pinhole diameter set for 1 Airy Unit.  Excitation of Texas Red was by 
illumination with the 543-nm line set at 74% transmission, and emission collected using 
a variable bandpass filter set to 555-655 nm.  Excitation for FITC was accomplished by 
illumination with the 488-nm line set at 1.4% transmission, and emission collected using 
a variable bandpass filter set at 500-543 nm.  All images were acquired at 1024x1024 
pixels at 4.0 µs/pixel and were analyzed in ImageJ version 1.42q (NIH).  Membrane 
Fluorescence (FM) was determined using the mean fluorescence of a region of interest 
(ROI) isolating the membrane, and Total Fluorescence was determined using the mean 
fluorescence of the ROI for the cytosol of the total cell.   
 
Electrophysiological Recordings.   
 Isolated smooth muscle cells were placed into a recording chamber (Warner 
Instruments) and allowed to adhere to glass coverslips for 20 min at room temperature.  
Whole-cell currents were recorded using an AxoPatch 200B amplifier equipped with an 
Axon CV 203BU headstage (Molecular Devices). Recording electrodes (1-3 MΩ) were 
pulled, polished, and coated with wax to reduce capacitance.  GΩ seals were obtained 
in a magnesium based physiological saline solution (Mg-PSS) containing (in mM) 5 KCl, 
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140 NaCl, 2 MgCl2, 10 HEPES, and 10 glucose.  Amphotericin B (40 µM) was included 
in the pipette solution to perforate the membrane.  Perforation was deemed acceptable 
if series resistance was less than 50 MΩ.  STOC and TICC activity were recorded in 
normal external bathing solution containing (in mM) 134 NaCl, 6 KCl, 1 MgCl2 2 CaCl2, 
10 HEPES, and 10 glucose at pH 7.4 (NaOH).  The pipette solution contained (in mM) 
110 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 HEPES, and 5 µM EGTA at pH 7.2 
(NaOH).  Additional external solutions include, Na+-free external solution containing (in 
mM) 134 N-methyl-D-glucamine (NMDG), 1 MgCl2, 2 CaCl2, 6 KCl, 10 HEPES, 10 
glucose at pH 7.4 (KOH); and Ca2+ free external solution containing 134 NaCl, 6 KCl, 1 
MgCl2 0.73 CaCl2, 1 EGTA, 10 HEPES, and 10 glucose at pH 7.4 (NaOH).  Currents 
were filtered at 1 kHz, digitized at 40 kHz, and stored for subsequent analysis.  Clampex 
and Clampfit versions 10.2 (Molecular Devices) were used for data acquisition and 
analysis, respectively.  For most experiments, isolated smooth muscle cells were held at 
a membrane potential (Em) of +20 mV or -70 mV, and all recordings are performed at 
room temperature (22°C).  In our recording solutions, the calculated reversal potential 
for total monovalent cations is -1.8 mV and -30.6 mV for monovalent anions (Cl-).  
STOCs were defined as transient events greater than 10 pA (more than one BKCa 
channel), and the frequency was calculated by dividing the number of events by the 
time between the first and last event.  TICC activity at -70 mV was calculated as the 
sum of the open channel probability (NPo) of multiple open states of 1.75 pA.  This 
value was based on the reported unitary conductance of TRPM4 (25 pS).  Channel 











 1  
Where: 
tj = time spent in seconds with j = 1,2,….N channels open 
N = max number of channels observed  
T = duration of measurement. 
 
Calculations and Statistics.  
  All data are means ± SE.  Values of n refer to the number of cells for 
immnocytochemistry and patch clamp experiments.  Data were compared using paired 
t-tests.  A level of P ≤ 0.05 was accepted as statistically significant for all experiments.  
All histograms were constructed in Origin 8.1 (OriginLab Corp.). 
 
RESULTS  
Sustained Transient Cation Channel Activity in Freshly Isolated Smooth Muscle Cells.   
The amphotericin B perforated patch clamp configuration, which allows for 
membrane voltage control with minimal disruption of intracellular Ca2+ dynamics (71) 
was used to record TRPM4 currents in native cerebral artery myocytes.  Following seal 
formation and perforation, cells were voltage clamped at +20 mV and STOCs were 
recorded to demonstrate cell viability (Figure  2.1A).  STOC frequency was 2.8 ± 0.7 Hz 
with an average amplitude of 22.7 ± 2.4 pA (Figure  2.1A).  Cells were then voltage 
clamped at -70 mV to record inward currents.  Under these conditions, we observed 
rapidly opening and closing, or “flickery”, currents (TICCs) with an average amplitude of 
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-8.6 ± 1.6 pA (n = 8)  and a frequency of 19.5 ± 2.9 Hz (n = 5) (Figure  2.1B).  When 
physiological intracellular Ca2+ signaling activity is maintained, we are able to resolve 
single-channel TRPM4 currents using this method.  The high TICC frequency suggests 
that on average, and under these conditions, at least one TRPM4 channel is open.  
TICCs could be recorded for as long as seal viability could be maintained, up to 30 
minutes for some cells. The total open probability (NPo) for TICCs recorded under 
control conditions have mean value for 0.75 ± 0.08 and passed the Shapiro-Wilk test for 
normality (p = 0.184).  A peak amplitude histogram was constructed (Figure  2.1C) 
using the measured amplitude of channel(s).  Seven peaks (solid lines) were identified 
and are consistent with calculated current amplitude for multiple (1, 2, 3, etc) channels 
opening.  The apparent unitary TICC current amplitude at a holding potential of -70 mV 
was -1.7 ± 0.1 pA (n=5), and is consistent with the reported unitary conductance for 
TRPM4 channels (25 pS) (39, 95) (Figure  2.1C).  Additionally, we observe two peaks 
(dashed lines) that did not coincide with any predicted TRPM4 current amplitude peak. 
These peaks occur at -2.7 and -4.2 pA at -70 mV, and are suggestive of the presence of 
~38 pS and ~60 pS channels.  The reported unitary conductance for TRPC6 and 
TRPC3 are 35 pS (70) and 66 pS (204), respectively, and could account for these 
peaks. These currents account for a minor portion of TICC activity (~16%).   TICCs 
were eliminated when Na+ in the bathing solution was replaced with the non-permeable 
cation N-methyl-D-glucamine (NMDG) (Figure  2.1D).  To rule out the influence of BKCa 
channels, recording were made in the presence of the selective BKCa channel blocker 
paxilline (5 µM).  Paxilline abolished STOCs, but TICC activity was not changed (n = 3) 
demonstrating that these currents are independent of BKCa channel activity.   
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The mean peak amplitude (pA) of TICC activity was recorded in the presence of 
paxilline at different holding potentials between -80 and +80 mV to examine the current-
voltage (I-V) relationship.  TICCs displayed modest inward rectification, and consistent 
with cation current activity, reversed at ~0 mV (Figure  2.2). The calculated ionic 
reversal potentials for the solutions used for this study (symmetrical for total cations) is -
1.8 mV vs. -30.6 mV for Cl-. When Na+ is replaced by the non-permeable cation, 
NMDG, and in the presence of paxilline, TICCs are abolished. This lack of channel 
activity at different holding potentials suggests that we have isolated a Na+-dependent 
current. These findings demonstrate that perforated patch clamp configurations can be 
used to record sustained cation currents in freshly isolated cerebral smooth muscle 
cells.  
TICC activity was recorded in the presence of reported pharmacological 
inhibitors of TRPM4.  Fluflenamic acid has been previously reported to inhibit TRPM4 
(EC50 = 2.8 µM) and TRPM5 (EC50 = 24.5 µM) currents (186).  TICC activity was absent 
following the administration fluflenamic acid (10 µM) (n=5, Figure  2.3A).  The 
hydroxytricyclic derivative, 9-phenanthrol, has also been shown to specifically inhibit 
TRPM4 and not the closely related channel TRPM5 (60). TICC activity was diminished 
following the administration of 9-phenanthrol (n=3, 100 µM) (Figure  2.3B).  These 
findings demonstrate that TICC activity is suppressed by compounds known to block 
TRPM4, suggesting that in smooth muscle cells, TICCs are whole-cell TRPM4 currents 




TRPM4 siRNA Selectively Silences TRPM4 Expression.   
To test the hypothesis that TRPM4 expression is required for TICC activity, we 
suppressed expression of the channel using RNA interference (RNAi) technology.  
TRPM4 specific or control siRNA molecules were introduced into isolated cerebral 
arteries using a reversable permeabilization technique (194).  Arteries were cultured for 
two to three days after siRNA treatment to allow for down-regulation before smooth 
muscle cells were enzymatically dispersed from the vessels.  In some experiments 
Alexa-555 tagged control siRNA was introduced into permeabilized arteries.  Using 
fluorescence confocal microscopy, we found that approximately 70-80% of the isolated 
smooth muscle cells contained tagged siRNA (Figure  2.4A), consistent with the findings 
of a prior study (21).  Quantitative real time RT-PCR was used to evaluate the effects of 
TRPM4 siRNA on TRPM4 mRNA levels.  We found that TRPM4 mRNA levels in 
arteries treated with siRNA against TRPM4 were 60-70% less compared to negative 
siRNA treated vessels (Figure 2.4B).   
A quantitative immunocytochemical approach was used to characterize the 
effects of TRPM4 siRNA on TRPM4 protein expression (Figure  2.4C).  Cell 
fluorescence was normalized as a ratio of membrane fluorescence (FM) to total cytosolic 
fluorescence (FT), where a (FM/FT) value significantly greater than 1.0 indicates 
increased labeling near the plasma membrane.  Control cells not exposed to primary 
antibodies have a FM/FT value of 1.1 (n=10).  Cells isolated from vessels treated with 
control siRNA and incubated with the appropriate TRPM4 primary antibody, have a 
FM/FT value of 4.1 (n=30), comparable to that of cells from freshly isolated cerebral 
arteries (FM/FT=5.4, n=15).  In TRPM4 siRNA treated vessels there are two distinct 
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populations of fluorescently labeled isolated cells.  Most (23 of 29 cells, 79.3%) of the 
cells from this group exhibit only background fluorescence levels (FM/FT=1.2) (Figure  
2.4C), suggesting that down regulation of TRPM4 expression is nearly complete in cells 
that take up the siRNA.  A second, smaller population of cells (6 of 29 cells, 20.7%), 
exhibit fluorescence similar to that of cells isolated from vessels treated with control 
siRNA (FM/FT=4.2) (Figure  2.4C).  These findings suggest that silencing of TRPM4 
expression is nearly complete in the ~70-80% of cells that take up siRNA. 
To test whether TRPM4 siRNA alters the relative protein expression levels of 
other TRP channels, we used the same quantitative immunocytochemical approach.   
TRPC3 and TRPC6 channels are present in cerebral artery smooth muscle cells and 
influence membrane potential and vascular tone (152, 173, 194).  Cells were isolated 
from vessels treated with TRPM4 or control siRNA and fluorescently labeled for TRPC3 
or TRPC6.  Treatment with TRPM4 siRNA had no effect on total TRPC3 or TRPC6 cell 
fluorescence compared with cells isolated from control siRNA treated vessels (Figure  
2.4D).  These findings demonstrate that our siRNA procedures diminishes TRPM4 
mRNA and protein levels and do not alter expression of other TRP channels involved in 
smooth muscle cell function. 
 
TRPM4 Expression is Required for TICC Activity.  
 To further examine the hypothesis that TRPM4 expression is required for TICC 
activity, we studied the effects of TRPM4 siRNA on STOCs and TICCs.   Smooth 
muscle cells enzymatically isolated from siRNA treated cerebral arteries were patch 
clamped in the perforated-patch configuration, and STOC and TICC activity were 
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recorded in the same cells at +20 mV and -70 mV, respectively (Figure  2.5A and B).  
The frequency and average amplitude of STOCs did not differ between cells isolated 
from cerebral arteries treated with TRPM4- versus control-siRNA (Figure  2.5C).  These 
findings show that the siRNA treatment does not disrupt BKCa channel activity or 
intracellular Ca2+ release events that generate STOCs.  In contrast, TRPM4 siRNA 
nearly abolished TICC activity (Figure  2.5A, B, and D).  Although some channel activity 
was observed in cells isolated from TRPM4 siRNA treated arteries, these events were 
less frequent and smaller in amplitude compared with TICC recordings from control 
siRNA treated vessels (Figure  2.5A and B, right).  The total open probability (NPo) for 
TICC activity in smooth muscle cells dispersed from cerebral arteries treated with 
TRPM4 siRNA was significantly less than from cells from vessels treated with control 
siRNA (Figure  2.5D).  These findings support the hypothesis that the molecular identity 
of the channel responsible for TICCs recorded from cerebral artery myocytes under 
perforated patch clamp conditions is TRPM4.  
 
TICCs are Activated by IP3R-dependent SR Ca
2+ Release.     
Previous work has shown that TRPM4 activation requires intracellular Ca2+ 
concentrations greater than resting cytosolic levels reported for native smooth muscle 
cells (95, 127, 129).   We propose that under physiological conditions, TRPM4 channels 
are activated by locally elevated levels of intracellular Ca2+ that result from influx of Ca2+ 
from the extracellular space or from release of Ca2+ from intracellular stores.   To 
determine if Ca2+ influx activates TRPM4, we recorded TICC activity during removal of 
extracellular Ca2+. Lack of extracellular Ca2+ did not acutely (within two minutes) disrupt 
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TICC activity, but prolonged exposure (greater than 5 minutes) to a Ca2+-free bathing 
solution eventually resulted in decreased TICC activity (Figure  2.6A).  These findings 
suggest TICC activity is not dependent on Ca2+ influx per se, but Ca2+ influx may be 
important in maintaining SR Ca2+ stores at levels sufficient to support channel activity.  
To examine this idea, we recorded TICC activity following disruption of SR Ca2+ stores, 
and found that inhibition of the SERCA pump with cyclopizonic acid (CPA, 10µM) 
attenuated TICC activity (Figure  2.6B). 
 To further examine the role of SR Ca2+ stores in the activation of TRPM4 in 
smooth muscle cells, we used ryanodine to disrupt ryanodine receptor (RyR) function, 
and the selective IP3R blocker, Xestospongin C, to inhibit SR Ca
2+ release events.  
Ryanodine (50 µM) eliminated STOCs (n=4), but had no effect on the TICC activity over 
the same time course (Figure  2.7A).  In contrast, administration of Xestospongin C (1 
µM) did not alter STOC frequency or amplitude (n=5), but TICC activity was greatly 
diminished (Figure  2.7B).  These findings suggest that in native cerebral artery 
myocytes, TRPM4 is activated by Ca2+ released from the SR through IP3R (Figure  2.8).  
 
DISCUSSION  
The current study demonstrates a new method for recording sustained TRPM4 
channel activity in freshly isolated smooth muscle cells.  An important feature of this 
technique is the ability to record cation currents with minimal disruption of intracellular 
Ca2+ signaling dynamics. This patch clamp method was used to examine the 
mechanism of Ca2+-dependent regulation of the channel in native smooth muscle cells.  
Our major findings are: (1) Sustained Transient Inward Cation Currents (TICCs) can be 
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recorded from cerebral artery myocytes using the perforated patch clamp configuration; 
(2) RNAi-mediated down regulation of TRPM4 expression attenuates TICC activity; and 
(3) TRPM4-dependent TICC activity is independent of Ca2+ influx per se but is 
attenuated by blockade of SERCA pump activity and IP3R-mediated SR Ca
2+ release.  
These findings provide the first sustained whole-cell recordings of TRPM4 activity in 
native smooth muscle cells with intact intracellular Ca2+ signaling and are the first 
demonstration of regulation of TRPM4 activity by IP3R-mediated SR Ca
2+ release. 
TRPM4 channels are necessary for pressure- and PKC-induced smooth muscle 
depolarization and vasoconstriction (40, 43), and the autoregulation of cerebral blood 
flow in vivo (151).  Efforts to understand regulation of TRPM4 have been hampered by 
rapid (~2 min) desensitization under conventional patch clamp conditions when 
nonphysiological levels of Ca2+ (~10-100 µM) are present in the intracellular solution.  
Inhibition of phospholipase C (PLC) prolongs TRPM4 activity under these conditions, 
suggesting that a Ca2+-activated PLC isoform is responsible for TRPM4 rundown (126, 
202).  PLC-dependent desensitization of TRPM4 may result from localized depletion of 
phosphatidylinositol 4,5-bisphosphate (125, 202).  We propose that rapid 
desensitization of TRPM4 activity is an artifact of recording conditions rather than an 
inherent property of the channel.  To test this possibility, we sought a method that would 
allow whole-cell TRPM4 currents to be recorded under native conditions.  The 
amphotericin B perforated patch clamp configuration allows whole cell currents to be 
recorded with minimal disruption of subcellular Ca2+ signaling pathways (71). This 
technique has been successfully used to record BKCa channel activation in smooth 
muscle cells in response to Ca2+ sparks (120), and we reasoned that this technique 
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could also be used to record whole-cell TRPM4 currents activated by transient Ca2+ 
events.  We find that sustained currents (TICCs) recorded from native cerebral artery 
myocytes under these conditions. TICCs have a high frequency of occurrence (19.5 ± 
2.9 Hz), but this is not unexpected. Our previous work shows that TRPM4 activity can 
be recorded from ~50% of inside-out membrane patches pulled from freshly isolated 
smooth muscle cells, suggesting that TRPM4 channels are abundant in these cells (43).  
Additionally, TICCs have biophysical properties that are consistent with those of 
TRPM4.  For example, TICCs have and an apparent single channel conductance of ~25 
pS, in agreement with the reported unitary conductance of TRPM4 (134, 138, 199).  
TICCs reversed at ~0 mV in the symmetrical cationic solutions used for this study (ECl = 
-30.6 mV) and substitution of the impermeant cation NMDG for Na+ in the bathing 
solution completely blocked TICC activity.  These findings are consistent with the 
selectivity of TRPM4 for monovalent cations (95, 127).   Furthermore, TICCs were 
suppressed by the TRPM4 blockers fluflenamic acid and 9-phenanthrol, supporting the 
hypothesis that TRPM4 is the major channel responsible for this activity.  We further 
probed the relationship between TICCs and TRPM4 using siRNA-mediated 
downregulation of TRPM4 expression.  The efficacy and specificity of our TRPM4 
siRNA treatment was confirmed using immunocytochemistry.  Our data suggest that 
~80% of smooth muscle cells take up the TRPM4 siRNA and exhibit nearly complete 
knockdown of TRPM4 protein expression.  Additionally, cells isolated from TRPM4 
siRNA vessels did not show a change in expression of TRPC3 or TRPC6 protein.  TICC 
activity is decreased in smooth muscle cells isolated from arteries treated with TRPM4-
specific siRNA compared to cells isolated from vessels treated with negative control 
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siRNA.  Thus, we conclude that TICCs represent TRPM4 activity in native cerebral 
artery myocytes. The virtually total inhibition  of TICCs following treatment with TRPM4 
siRNA suggest that most of the cells used for these experiments come from the 
population of cells that received siRNA and have nearly complete knockdown of TRPM4 
expression. The perforated patch technique described here provides a novel method for 
recoding sustained TRPM4 currents under near-physiological conditions and should be 
useful for further characterization of the channel in smooth muscle cells. 
We unexpectedly found that whole-cell single-channel TICC activity exhibits 
modest inward rectification.  In previous work, single channel recordings from inside-out 
patches exhibited a linear current-voltage relationship (43), whereas whole-cell TRPM4 
currents exhibited both inwardly and outwardly rectification (40, 127).  Dual rectification 
reported for conventional whole-cell TRPM4 currents may be an artifact of recording 
conditions. Under conventional whole-cell patch clamp conditions, the cytosolic 
environment is disrupted when the cell is dialyzed with the pipette solution, whereas the 
perforated-patch clamp configuration allows the intracellular environment to remain 
largely intact.  TRPM4 currents are blocked by the polyamine spermine (126, 132), 
which could be dialyzed from the cell under conventional whole-cell conditions.  
Polyamine block is responsible for inward rectification of inwardly-rectifying K+ (KIR) 
channels in vascular smooth muscle cells (135, 175). We propose that this mechanism 
is also responsible for inward rectification of TICCs and that this mechanism contributes 
to the voltage dependency of TRPM4 channels under physiological conditions in 
vascular smooth muscle cells.  Interestingly, the current-voltage relationship we report 
for TICC activity would result in increased depolarizing current in response to 
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membrane hyperpolarization and could be important for maintaining stable membrane 
potential in arterial myocytes.  
The level of intracellular Ca2+ required to activate TRPM4 channels in whole-cell 
and inside-out patch clamp experiments is far greater than the average cytosolic [Ca2+] 
of arterial myocytes (100-300 nM) (85).  However, downregulation of TRPM4 
expression impairs pressure-induced myocyte depolarization, vasoconstriction, and 
autoregulation of cerebral blow flow (43, 151), demonstrating that the channel is active 
under physiological conditions.  Subcellular regions of elevated Ca2+ can result from 
Ca2+ influx from the extracellular space (115, 165) and from Ca2+ released from 
intracellular stores (15, 77, 78, 107, 201), and these dynamic Ca2+ events can further 
regulate the activity of Ca2+-sensitive ion channels (120).  We tested the hypothesis that 
increases in intracellular Ca2+ activate TRPM4 in native smooth muscle cells.  We found 
that removal of extracellular Ca2+ did not initially change TICC activity, but prolonged 
exposure to Ca2+-free bathing solution eventually decreased these events, possibly due 
to diminished refilling of SR stores.   Blockade of the SERCA pump also diminished 
TICC activity, consistent with a role for SR Ca2+ release in TRPM4 regulation.  RyRs 
inhibition did not alter TICC activity, but these currents were decreased by the IP3R 
receptor blocker xestospongin C. These findings indicate that Ca2+ released from IP3Rs 
receptors activate TRPM4 channels in cerebral artery smooth muscle cells (Figure  2.8). 
Ca2+ release from IP3R is associated with the generation of “Ca
2+ puffs” which 
have been described in Xenopus oocytes (201) and isolated smooth muscle cells (8, 
15).  Our data suggests that some basal level of PLC-dependent generation of IP3 and 
IP3R-mediated Ca
2+ release is present in freshly isolated cerebral artery smooth muscle 
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cells and supports sustained TICC activity.  IP3R-mediated Ca
2+ release is also 
associated with spontaneous synchronous and asynchronous Ca2+ waves in smooth 
muscle cells in intact arteries (15, 77).  The physiological function of these Ca2+ 
signaling events is not fully understood.  Our findings show that TRPM4 activity in native 
cerebral artery myocytes requires IP3R-mediated SR Ca
2+ release, and we propose that 
TRPM4-mediated membrane depolarization in response to these Ca2+ signals may be 
central to vascular tone regulation.   Consistent with this hypothesis, it has been 
proposed that synchronous Ca2+ waves in intact vessels may coordinate the membrane 
potential of smooth muscle cells along a segment of the vascular wall to effect uniform 
arterial contraction (106).  Our findings suggest that TRPM4 activity could translate 
changes in synchronized Ca2+ waves into changes in smooth muscle cell membrane 
potential (140).  Alternatively, asynchronous Ca2+ wave frequency reportedly increases 
in the presence of contractile agonists (15, 77), and this response may be important for 
smooth muscle contraction (77).  It is possible that during agonist-stimulated increases 
in asynchronous Ca2+ wave activity, low, non-contractile amounts of Ca2+ are released 
from IP3Rs activate TRPM4 to depolarize the membrane and initiate Ca






Figure 2.1: Sustained Transient Cation Channel Activity in Freshly Isolated Smooth 
Muscle Cells.  A and B: Representative perforated-patch clamp recordings of 
Spontaneous Transient Outward Currents (STOC) and Transient Inward Cation 
Currents (TICC) in the same cell.  Representative of ~30 cells.  Insert shows 
expanded time scale.   C: Peak amplitude histogram of TICC activity recorded from 
freshly isolated smooth muscle (0.2 pA bins).  Data are fitted with multiple Gaussian 
functions. The solid-line peaks match calculated current amplitude for TRPM4 
channel openings. The dash-line peaks do not match with calculated current 
amplitude for TRPM4 channel openings.  D: Representative trace and summary data 
of TICC activity with Na+ replaced with the non-permeabale cation N-methyl-D-




  Figure 2.2: Current-Voltage Relationship for TICC Activity in Freshly Isolated Smooth 
Muscle Cells.  Sample traces of TICC recordings obtained at holding potentials (VH) 
from +80 to -70 mV.  Average current amplitude to voltage relationship (I/V) for cells 






Figure 2.3: TICC Activity is Blocked by TRPM4 inhibitors.  A: Representative trace 
and summary data of TICC activity in the presence of the fluflenamic acid (10 µM, 
n=5).  B: Representative traces of TICC activity in the presence of 9-phenanthrol 




   
Figure 2.4: siRNA-Mediated Knockdown of TRPM4 Expression in Freshly Isolated 
Smooth Muscle Cells.  A: Freshly isolated rat cerebral artery smooth muscle cells 
from arteries treated with control siRNA tagged with Alexa 555 (top) or untagged 
siRNA (bottom).  Scale Bar = 11 µm. B: Summary data for siRNA-mediated down-
regulation of TRPM4 mRNA levels in cerebral arteries as determined through real 
time, quantitative RT-PCR (n=3). C. Frequency histogram of the normalized 
membrane fluorescence (FM/FT) from cells: with no 1° antibody (n=10, grey); isolated 
from TRPM4-siRNA treated vessels (n=30, blue); and control siRNA treated vessels 
(n=30, black).  Surface plot representatives of images obtained for each treatment 
(right). Scale Bar = 10 µm. D. Summary data of TRPM4-siRNA vs. control siRNA 
treatment on the total cell fluorescence labelling for TRPM4 (n=40), TRPC3 (n=30), 
and TRPC6 (n=20). *P≤0.05 vs. control siRNA.  Representative images of total 





Figure 2.5: TRPM4 Expression is Required for TICC Activity. A: Representative 
recordings of STOC and TICC activity from the same cell isolated from arteries 
treated with control siRNA.  B: Representative recordings of STOC and TICC activity 
from the same cell isolated from arteries treated with TRPM4 siRNA.  C: Summary 
data of STOC frequency (f, top) and average STOC amplitude (bottom).  D: TICC 
NPo for vessels treated with control siRNA (n=4) or TRPM4 siRNA (n=5). *P≤0.05 vs. 





  Figure 2.6: TICC are Activated by SR Ca
2+ Release. A. Representative trace and 
summary data of TICC activity in the presence of extracellular Ca2+ (n=6) and at 30 
sec [1] (n=6) and ~5 minutes [2] (n=6) after extracellular Ca2+ is removed.  B: 
Representative trace and summary data of TICC activity in the presence of the 





Figure 2.7: TICCs are Activated by IP3R-dependent SR Ca
2+ Release. A: 
Representative traces of STOC and TICC activity in the presence of the SR 
ryanodine receptor antagonist ryanodine (50 µM). Summary data of TICC NPo (right, 
n=4).  B: Representative traces of STOC and TICC activity in the presence of the 





  Figure 2.8: Activation of TRPM4 by IP3R-Mediated SR Ca
2+. VGCC, voltage-gated 
calcium channels; ∆Vm, change in membrane potential; TRPM4, transient receptor 
potential melastatin 4; PM, plasma membrane; SR, sarcoplasmic reticulum; IP3R, 





Endogenous Cytosolic Ca2+ Buffering is Necessary for TRPM4 Activity in Cerebral 
Artery Smooth Muscle Cells 
 
INTRODUCTION 
The melastatin (M) Transient Receptor Potential (TRP) channel TRPM4 is a 
crucial mediator of pressure-induced vascular smooth muscle membrane depolarization 
and vasoconstriction, and is essential for autoregulation of cerebral blood flow (43, 58). 
High levels of intracellular Ca2+ (1-10 µM) are required for activation of TRPM4 (128), 
and under inside-out (28, 40, 43) or traditional whole cell patch configuration (40, 125),  
Ca2+ is introduced in order to activate and record TRPM4 currents.  However, under 
these conditions TRPM4 also undergoes fast, Ca2+-dependent inactivation, and currents 
decay to baseline  levels within 3 minutes (40, 43, 94, 126, 132).  TRPM4 channel 
activity can be rescued from inactivation by inhibition of phospholipase C (PLC) activity 
or by inclusion of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate 
(PIP2) in the intracellular solution (125, 202).  These findings suggest that high global 
levels of Ca2+ used to record TRPM4 currents in traditional whole cell and inside-out 
patch clamp configurations activate a Ca2+-dependent PLC isoform (153) that 
inactivates the channel by depleting PIP2.   It is possible that Ca
2+-dependent 
inactivation precludes observation of TRPM4 currents during patch clamp experiments, 
leading to under-estimation of channel activity under native conditions. We recently 
identified Transient Inward Cation Currents (TICCs) as sustained TRPM4 channel 
activity in freshly isolated smooth muscle cells (55).  These currents can be 
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continuously recorded for as long as 30 minutes using the whole cell perforated patch 
clamp configuration (55), a method that restricts cell dialysis and causes minimal 
disruption of the intracellular environment, allowing global and local Ca2+ dynamics to 
function naturally.  Thus, Ca2+-dependent inactivation of TRPM4 may not be an inherent 
property of the channel itself but is a consequence of recoding methods. However, the 
mechanisms underlying this phenomenon are not clear. The goal of the current study is 
to determine how Ca2+-dependent activation of TRPM4 currents is maintained in 
cerebral artery smooth muscle cells under native conditions.   
Subcellular regions with Ca2+ levels much greater than the global [Ca2+] result 
from Ca2+ influx from the extracellular space (115, 165) or from Ca2+ released from 
intracellular stores (15, 78, 79, 107, 201).  The temporal and spatial characteristics of 
these  small Ca2+ domains are shaped by the magnitude and duration of the initial Ca2+ 
signal, and by  Ca2+ removal and intrinsic Ca2+ buffering within the cytosol (99).  For 
example, the  plasma membrane  Ca2+-ATPase (PMCA), the Na+/Ca2+ exchange  
system, the sarco(endo)plasmic reticulum  Ca2+-ATPase  (SERCA), and Ca2+ 
sequestering in the mitochondria and  nucleus (99) all actively remove Ca2+ from the 
intracellular space.  Additionally, cytosolic proteins, such as calmodulin, calpain, and 
troponin C, bind Ca2+ and limit the availability of free intracellular Ca2+ (184).  These 
Ca2+ buffering mechanisms are essential for insuring the transient nature of intracellular 
Ca2+ signaling events by limiting spatial spread and preventing prolonged high cytosolic 
Ca2+ levels.  
Localized, transient increases in cytosolic Ca2+ can directly activate Ca2+-
sensitive ion channels (78, 192) in vascular smooth muscle cells.  Our laboratory 
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recently reported loss of TRPM4 channel activity following specific inhibition of the SR 
inositol Ca2+ release channel, 1,4,5-trisphosphate receptor (IP3R) (55), suggesting that 
subcellular cytosolic Ca2+ domains also activate TRPM4 channels in the plasma 
membrane in native smooth muscle cells.  However, the role of endogenous Ca2+ 
buffering in regulation of TRPM4 activity has not been reported.  We hypothesized that 
under conventional whole cell conditions, loss of intrinsic cytosolic Ca2+ buffering 
following cellular dialysis contributes to Ca2+-dependent inactivation of TRPM4 
channels.  To test this hypothesis, we examined the consequences of manipulating 
intracellular Ca2+ buffering on TRPM4 activity in freshly isolated cerebral myocytes.  In 
the absence of cytosolic Ca2+ buffering, we found that TICC activity quickly dissipated 
with the same inactivation kinetics as recombinant TRPM4 activity recorded in the 
presence of high global Ca2+ under conventional whole cell conditions.  Using 
conventional whole cell patch clamp electrophysiology, we recorded sustained, TICC-
like currents (whole-cell TICCs) with ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA) or 2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 
(BAPTA) added to the intracellular recording solution at concentrations (10 and 0.1 mM, 
respectively) that mimic the effects of endogenous Ca2+ buffering.  These currents were 
pharmacologically and biophysically identical to TRPM4-dependent currents recorded 
under perforated patch clamp conditions.  Higher concentrations of BAPTA abolished 
these currents, demonstrating that TRPM4 channels are present on the plasma 
membrane very near, but not physically coupled to, IP3Rs. This conclusion is supported 
by TRPM4 and IP3R immunolabeling experiments. This study demonstrates that intact 
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endogenous Ca2+ buffering is required to maintain TRPM4 channel activity in smooth 
muscle cells. 
 
MATERIAL AND METHODS 
Animals  
Male Sprague-Dawley rats (250–350 g; Harlan) were used for these studies. 
Animals were deeply anesthetized with pentobarbital sodium (50 mg ip) and euthanized 
by exsanguination according to a protocol approved by the Institutional Animal Care and 
Use Committees (IACUC) of Colorado State University.  Brains were isolated in cold 3-
(N-morpholino) propanesulfonic acid (MOPS)-buffered saline (in mM): 3 MOPS (pH 
7.4), 145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 2 pyruvate, and 5 
glucose and 1% bovine serum albumin. Cerebral and cerebellar arteries were dissected 
from the brain, cleaned of connective tissue, and stored in MOPS-buffered saline prior 
to further manipulation.   
 
 A7r5 Cell Culture and Transient DNA Transfection 
A7r5 cells (ATCC) were cultured in Dulbecco’s 1X High Glucose Modified Eagle 
Medium (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 0.5% penicillin-
streptomycin (Gibco). Cells were maintained at 37°C with 6% CO2, media was changed 
every two to three days, and cells were sub-cultured when confluent using 0.25% 
trypsin-EDTA (Gibco).  A7r5 cells were transiently transfected with a plasmid encoding 
a TRPM4-GFP fusion protein (23) with the aid of Effectene Transfection Reagent 
(Qiagen) according to manufacturer’s instructions for adherent cells. Media was 
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changed 24 hours after transfection, and cells were cultured for 1-2 days prior to 
electrophysiology experiments.  
 
Isolation of Cerebral Artery Smooth Muscle Cells 
Vessels were placed on ice in a magnesium-based physiological saline solution 
(Mg-PSS) containing (in mM) 5 KCl, 140 NaCl, 2 MgCl2, 10 HEPES, and 10 glucose.  
 Arteries were initially digested in 0.6 mg/mL papain (Worthington) and 1 mg/mL 
dithioerythritol at 37°C for 17 minutes, followed by a 15 minute incubation at 37°C in 1.0 
mg/ml type II collagenase (Worthington).  The digested segments were washed three 
times in ice-cold Mg-PSS solution and incubated on ice for 30 minutes.  Following this 
incubation period, vessels were triturated to liberate smooth muscle cells and stored in 
ice-cold Mg-PSS for use.  Smooth muscle cells were studied within 6 hours following 
isolation.  
 
RNAi and Reversible Permeabilization 
Small interfering RNAs (siRNA) against TRPM4 were used to down-regulate 
expression of the channel in isolated cerebral arteries (55).  siRNA molecules 
purchased from Qiagen (1027280 [AllStars Negative Control], SI02868292 
[Rn_Trpm4_1], and SI02868313 [Rn_Trpm4_4]) were dissolved as instructed at a 
concentration of 20 μM in siRNA Suspension Buffer. Control siRNA or TRPM4 siRNA 
molecules were introduced into intact cerebral arteries using a reversible 
permeabilization procedure.  To permeabilize the arteries, segments were first 
incubated for 20 minutes at 4oC in the following solution (in mM): 120 KCl, 2 MgCl2, 10 
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EGTA, 5 Na2ATP, and 20 TES; (pH 6.8).  Arteries were then placed in a similar solution 
containing siRNA (40 nM) for 3 hours at 4oC and then transferred to a third siRNA-
containing solution with elevated MgCl2 (10 mM) for 30 minutes at 4°C.  
Permeabilization was reversed by placing arteries in a MOPS-buffered physiological 
siRNA-containing solution consisting of (in mM): 140 NaCl, 5 KCl, 10 MgCl2, 5 glucose, 
and 2 MOPS; (pH 7.1) for 30 minutes at room temperature.  Ca2+ was gradually 
increased in the latter solution from nominally Ca2+-free to 0.01, 0.1, and 1.8 mM over a 
45 minute period.  Following these procedures, arteries were cultured for two to three 
days in D-MEM/F-12 culture media supplemented with L-glutamine (2 mM) (Gibco), and 
0.5% penicillin-streptomycin (Gibco).  Arteries were then used for smooth muscle cell 
isolation. 
 
Immunocytochemistry and Membrane Staining.  
Cells were enzymatically dissociated from cerebral vessels as described above, 
and allowed to adhere to glass slides for 20 minutes at 4°C.  Cells were fixed with 4% 
formaldehyde for 10 minutes, permeabilized with cold methanol (-80°C), blocked with 
2% bovine serum albumin, and incubated with primary antibodies overnight at 4°C. The 
following primary antibodies were used as appropriate: goat anti-TRPM4 at 1:50 (sc-
27540, Santa Cruz) and rabbit anti-IP3R at 1:50 (AB1622, Chemicon).  Cells were 
subsequently washed and incubated with appropriate fluorescent secondary antibody 
for 2 hours at room temperature.  The following secondary antibodies were used as 
appropriate; anti-rabbit conjugated to Texas Red, (sc-2780, Santa Cruz) and anti-goat 
conjugated to FITC, (sc-2704, Santa Cruz).  Membrane specific fluorescent staining 
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was performed using 5 µg/mL ER-TrackerTM Green (Invitrogen), 5 µg/mL ER-TrackerTM 
Red (Invitrogen), or 5 µg/mL CellMaskTM Deep Red (Invitrogen).  For specific plasma 
membrane staining, cells were incubated in CellMaskTM Deep Red in Mg-PSS for 10 
minutes at 37°C.  For specific SR membrane staining, cells were incubated in ER-
TrackerTM Green or ER-TrackerTM Red in MgPSS for 30 minutes at 37°C.  For dual 
membrane staining, the cells were incubated in ER membrane stain, washed, and 
incubated in plasma membrane stain.  For simultaneous immunocytochemistry and 
membrane staining, fixed cells were first immunolabeled for the appropriate protein and 
then incubated in the specific membrane stain.  Fluorescent images were obtained 
using a spinning disk confocal microscope (Andor) and a 100x oil immersion objective.  
Excitation of Texas Red and FITC was by illumination with the 543-nm line and 488-nm 
line, respectively. Immunofluorescence was not detected in cells probed with secondary 
antibody alone.  All images were acquired at 1024x1024 pixels and were analyzed 
using Volocity 6.0 (PerkinElmer). 
 
General Electrophysiological Recordings 
Currents were recorded using an AxoPatch 200B amplifier equipped with an 
Axon CV 203BU headstage (Molecular Devices). Recording electrodes (1-3 MΩ) were 
pulled, polished, and coated with wax to reduce capacitance.  Currents were filtered at 1 
kHz, digitized at 40 kHz, and stored for subsequent analysis.  Clampex and Clampfit 
versions 10.2 (Molecular Devices) were used for data acquisition and analysis, 




Electrophysiological Recording Solutions  
 Macroscopic whole cell currents from HEK 293 cells transfected with TRPM4-
GFP were recorded in external bathing solution containing (in mM): 146 NaCl, 5 CaCl2, 
10 HEPES, and 10 Glucose (pH = 7.4). The bathing solution was supplemented with the 
potassium channel blocker TEA (10 mM).  The pipette solution contained (in mM): 146 
CsCl, 1 MgCl2, 10 HEPES and 0.1CaCl2.  TICC activity recorded under perforated patch 
clamp conditions was performed in external bathing solution containing (in mM): 134 
NaCl, 6 KCl, 1 MgCl2 2 CaCl2, 10 HEPES, and 10 glucose at pH 7.4 (NaOH).  The 
pipette solution contained (in mM): 110 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 
HEPES, and 5 µM EGTA at pH 7.2 (NaOH).  TICC activity recorded under whole-cell 
patch clamp conditions was performed in external bathing solution containing (in mM): 
140 NaCl,  5 CsCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose at pH of 7.4 (NaOH). 
The pipette solution contained (in mM): 20 CsCl, 87 K-aspartate, 1 MgCl2, 5 MgATP, 
and 10 HEPES (pH 7.2, CsOH).  External solution with the K+ channel blocker 
tetraethylammonium (TEA) contained (in mM): 130 NaCl, 10 TEA, 5 CsCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, and 10 glucose at pH 7.4.  Additional external solutions include, 
Na+-free external solution containing (in mM): 140 N-methyl-D-glucamine (NMDG), 5 
CsCl2, 1 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose at pH 7.4 (HCl); and Ca
2+ free external 
solution containing (in mM): 130 NaCl, 5 CsCl2 1 MgCl2 0.73 CaCl2, 1 EGTA, 10 





Electrophysiological Recordings from TRPM4-Expressing A7r5 Cells 
 Conventional whole cell patch clamp studies were conducted using non-
transfected A7r5 cells or cells transiently transfected with TRPM4-GFP (23).  
Transfected cells were identified by the presence of green fluorescence.  Cells were 
initially held at a membrane potential of 0 mV.  Currents were measured during voltage 
ramps between -100 and +100 mV (time of ramp) repeated every 4 seconds.  
 
Electrophysiological Recordings from Isolated Smooth Muscle Cells  
Freshly isolated cerebral artery smooth muscle cells were placed into a recording 
chamber (Warner Instruments) and allowed to adhere to glass coverslips for 20 minutes 
at room temperature.  GΩ seals were obtained in Mg-PSS.  For perforated whole cell 
patch clamp recordings, amphotericin B (40 µM) was included in the pipette solution.  
Perforation was deemed acceptable if series resistance was less than 50 MΩ.  For 
conventional whole cell patch clamp recordings, isolated smooth muscle cells were 
voltage clamped at a membrane potential (Em) of -70 mV.  In our recording solutions, 
the calculated reversal potential for total monovalent cations is 7.7 mV and -48.9 mV for 
monovalent anions (Cl-).  TICC activity at -70 mV was calculated as the sum of the open 
channel probability (NPo) of multiple open states with unitary amplitude of 1.75 pA (i.e. 1 
open state).  This value was based on the reported unitary conductance of TRPM4 (25 








tj = time spent in seconds with j = 1,2,….N channels open 
N = max number of channels observed  
T = duration of measurement. 
 
Calculations and Statistics 
All data are means ± SE.  Values of n refer to the number of cells for patch clamp 
experiments.  Data were compared as indicated using paired t-tests or one-way 
repeated measures analysis of variance (ANOVA).  A level of P ≤ 0.05 was accepted as 
statistically significant for all experiments.  All peak amplitude histograms were 
constructed using Origin 8.1 (OriginLab Corp.). 
 
RESULTS 
Disruption of the Intracellular Environment Leads to Ca2+-Dependent TRPM4 
Inactivation.   
Under traditional whole cell patch clamp configurations, TRPM4 currents 
recorded from recombinant channels expressed in HEK 293 cells, or from native 
channels in freshly isolated cerebral artery myocytes, exhibit rapid, Ca2+-dependent 
inactivation (40, 128).  To better characterize the time course of TRPM4 inactivation we 












cells and native TRPM4 channel activity in freshly-isolated smooth muscle cells.  
Currents were obtained from A7r5 cells transfected with TRPM4-GFP (23) using the 
conventional whole cell configuration with 100 µM Ca2+ included in the patch pipette 
solution.  As expected, in the presence of high cytosolic Ca2+ levels, cation currents 
exhibited outward rectification and rapid inactivation (Figure  1A).  Peak TRPM4-GFP 
currents (black arrowhead, n=5) decreased by 26 ± 6% at 8 seconds (grey arrowhead) 
and 60 ± 5% at 60 seconds (white arrowhead).  These findings are consistent with 
previous reports of TRPM4 channel activity in HEK 293 cells (40, 128) and demonstrate 
that recombinant TRPM4 channel currents in A7r5 cells quickly dissipate following 
prolonged exposure to high global Ca2+. 
In native cerebral artery smooth muscle cells patch clamped under perforated 
patch conditions (leaving the intracellular environment undisturbed), TRPM4 currents 
manifest as TICCs. TICCs can be recorded under perforated patch conditions for as 
long as seal integrity can be maintained.  We recorded TICC activity under perforated 
patch clamp conditions (PP, Figure  3.1B) and TICC-like currents under conventional 
whole cell patch clamp (WC, Figure  3.C) configuration without the addition of Ca2+ to 
the pipette solution.  TICCs recorded under perforated patch conditions did not 
inactivate, while under whole cell conditions we observed time-dependent decay of 
TICC-like activity. Activity decreased by 16 ± 10% at 10 seconds and by 64 ± 6% at 60 
seconds following cellular dialysis.  The time course of inactivation of whole cell TRPM4 
currents recorded from A7r5 cells (Figure  3.1A) and the decay of TICC activity in native 
cerebral artery smooth muscle cells (Figure  3.1B) are identical (Figure  3.1C), 
suggesting that inactivation results from a common mechanism.  Furthermore, these 
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findings are consistent with the hypothesis that in freshly isolated smooth muscle cells 
patch clamped under whole cell conditions, cytosolic Ca2+ levels are increased following 
cellular dialysis, disruption of the intracellular environment, and loss of intrinsic Ca2+ 
buffering.   
 
EGTA Emulates Endogenous Cytosolic Ca2+ Buffering.   
To examine the hypothesis that loss of intracellular Ca2+ buffering capacity during 
cellular dialysis under conventional whole cell conditions results in TRPM4 inactivation, 
we used established software (CalC version 6.0, (102)) to model the effects of different 
concentrations of the slow Ca2+ buffer EGTA on the linear spread of Ca2+released from 
a single IP3R (Ca
2+ puff).  The current strength and on- and off-times of Ca2+ puffs were 
assumed to be 0.2 pA, 17 ms, and 100 ms, respectively, (18, 171) and resting, free 
global Ca2+ was assumed to be 200 nM with a diffusion coefficient of 200 µMs-1 (5).  
Ca2+ movements during three buffering states were modeled: no buffering, endogenous 
smooth muscle cell buffering, and buffering with EGTA.  As a first order approximation, 
we modeled endogenous cytosolic Ca2+ buffering capacity of a cell with the mean of 
reported values (Table 1) for the most abundant Ca2+ binding protein calmodulin (CaM) 
at a reported concentration of 40 µM in smooth muscle cells (203).  Additionally, our 
model used the reported values for the diffusion coefficient, Ca2+ affinity, dissociation 
constant, and Ca2+ on- and off-rates for CaM and EGTA (Table 1) (5, 47, 112, 164, 203) 
and compared the diffusion of free Ca2+ within model cells containing different 
concentrations of EGTA with those of cells with endogenous buffering.    
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In cells modeled with endogenous Ca2+ buffering, Ca2+ levels decreased 
logarithmically with distance from the Ca2+ source (Figure  3.2).  Cells modeled with no 
Ca2+ buffering elicit a nearly linear relationship between [Ca2+] and the distance traveled 
from the Ca2+ source (Figure  3.2).  Thus, in the absence of Ca2+ buffering, Ca2+ levels 
are greater at any given point away from the Ca2+ source than what is predicted for 
native endogenous buffering conditions.  The no buffer condition models the 
conventional whole-cell patch clamp conditions used for the recording shown in Figure  
3.1B, resulting in time-dependent inactivation of TRPM4 currents. Thus, it is possible 
that TRPM4 inactivation under these conditions results from loss of endogenous Ca2+ 
buffering.  The effects of EGTA were also examined in our modeling experiments.  
These findings predict that at a concentration of 10 mM the buffering capacity of EGTA 
has the same effect on the spatial spread of Ca2+, up to 100 nm, as projected for 
endogenous intracellular Ca2+ buffers (Figure  3.2).  
  
Sustained TRPM4 Currents Under Conventional Whole Cell Patch Clamp Conditions. 
To test the hypothesis that depletion of Ca2+ buffering contributes to Ca2+-
dependent inactivation of TRPM4, we compared channel activity recorded in cerebral 
arterial myocytes under perforated and conventional whole cell configuration with EGTA 
(10 mM) included in the pipette.  Under perforated patch clamp conditions, TICCs have 
a frequency of 20.1 ± 1.6 Hz (n = 5) (Figure  3.3A).  To better characterize the channel 
activity, a peak amplitude histogram was constructed (Figure  3.3B) and 5 peaks (solid 
line) were identified at -1.70, -3.43, -5.02, -6.5, and -8.49 pA and are consistent with the 
calculated unitary current amplitude for 1 (-1.7 pA), 2 (-3.4 pA), 3 (-5.1 pA), 4 (-6.8 pA), 
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and 5 (-8.5 pA) TRPM4 channel openings as well as our previous findings (55).  These 
currents were compared to those recorded using the whole cell configuration with 10 
mM EGTA added to the pipette solutions.  Currents recorded under these conditions 
(Figure  3.3C) are reminiscent of TICCs recorded under perforated patch clamp 
conditions (Figure  3.3A).  For clarity, we refer to TICC-like currents recorded using the 
conventional whole cell configuration as “whole-cell TICCs”.  Whole-cell TICCs have a 
frequency of 20.1 ± 2.0 Hz (n = 5) (Figure  3.3C).  A peak amplitude histogram was 
constructed (Figure  3.3D) and 4 peaks (solid line) were identified with the calculated 
current amplitude for multiple TRPM4 channel openings.  The peaks in the histogram 
occur at -1.7, -3.3, -5.1, and -6.8 pA and are consistent with the calculated unitary 
current amplitude for TRPM4 and peaks we observed under perforated patch clamp 
conditions (Figure  3.3B). The correspondence of event frequency and peak amplitude 
histograms between the two methods suggests that whole-cell TICCs are identical to 
TICCs recorded under the perforated patch clamp conditions. 
Biophysical properties of whole-cell TICCs were compared with those of TICCs 
recorded under perforated patch clamp conditions and TRPM4 currents recorded using 
conventional whole cell and inside-out configurations. To rule out the influence of K+ 
channels, recordings were made in the presence of the broad-spectrum K+ channel 
blocker tetraethylammonium (TEA, 10 mM).  TEA had no effect on the total open 
probability (NPo) of current activity (n=4), demonstrating that these cation currents are 
independent of K+ channel activity (Figure  3.4A).  Whole-cell TICCs were eliminated 
when Na+ in the bathing solution was replaced with the non-permeable cation N-methyl-
D-glucamine (NMDG) (Figure  3.4B), indicating that currents are conducted by Na+ ions, 
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consistent with the selectivity of TRPM4 for monovalent cations.  To examine the 
voltage dependence of whole-cell TICCs, currents were recorded in the presence of 
TEA and at different holding potentials, with the mean current amplitude (I) plotted as a 
function of membrane potential (V).  Similar to the I/V relationships reported for TRPM4 
obtained under conventional conditions (40, 128), whole-cell TICCs displayed modest 
inward and outward rectification, and reversed at 5-10 mV, consistent with the reversal 
potential for monovalent cations (7.7 mV) calculated for solutions used in these 
experiments (Figure  3.4C).   
Pharmacological TRPM4 inhibitors were employed to provide further evidence 
that whole-cell TICCs result from TRPM4 channel activity.  Fluflenamic acid reportedly 
inhibits TRPM4 (EC50 = 2.8 µM) and TRPM5 (EC50 = 24.5 µM) currents (186).  Whole-
cell TICC activity was diminished following the administration of fluflenamic acid (10 µM) 
(Figure  3.5A).  The selective TRPM4 blocker 9-phenanthrol (30 µM) also attenuated 
whole-cell TICC activity (Figure  3.5B). At the concentration used for this study, 9-
phenanthrol inhibits TRPM4 and not TRPM5 (60), TRPC3, TRPC6, BKCa, KIR, KV,  and 
L-type Ca2+ channels (58). These findings demonstrate that whole-cell TICC activity is 
suppressed by TRPM4 blockers, suggesting that these currents are carried by TRPM4 
channels. 
To provide additional evidence for a link between TRPM4 and whole-cell TICCs, 
TRPM4 expression was silenced using siRNA. We previously reported that TRPM4 
siRNA specifically downregulates TRPM4 mRNA and protein expression but had no 
effect on TRPC3 or TRPC6 expression (55).  We found that whole-cell TICCs were 
present in arterial smooth muscle cells isolated from arteries treated with control siRNA, 
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whereas treatment with TRPM4-specific siRNA nearly abolished these currents (Figure  
3.5C).  Thus, whole-cell TICCs have properties similar to TICCs recorded under 
perforated patch clamp conditions and TRPM4 currents recorded using conventional 
methods. Furthermore, whole-cell TICC activity is attenuated by TRPM4 blockers and 
diminished in cells treated with TRPM4 siRNA. These finding indicate that the molecular 
identity of the channel responsible for whole-cell TICCs in native smooth muscle cells is 
TRPM4.  More importantly, our findings indicate that restoration of intracellular Ca2+ 
buffering to endogenous levels is sufficient to prevent Ca2+-dependent inactivation of 
TRPM4, suggesting that endogenous Ca2+ buffers are essential for preventing TRPM4 
channel inactivation in smooth muscle cells under native conditions. 
 
Whole-Cell TICCs are Activated by IP3R-dependent SR Ca
2+ Release.     
A prior study from our lab  showed that in cerebral artery smooth muscle cells 
patch clamped in the perforated patch configuration, TRPM4 is activated by Ca2+ 
release from IP3R (55).  To examine Ca
2+-dependent activation of TRPM4 channels 
under cytosolic EGTA-buffered conditions, we recorded whole-cell TICC activity 
following the removal of extracellular Ca2+ and during pharmacological manipulation of 
SR Ca2+ stores.  Removal of extracellular Ca2+ did not acutely disrupt whole-cell TICC 
activity, but extended exposure (3 minutes) to Ca2+-free bathing solution resulted in 
decreased activity (Figure  3.6A).  Following disruption of SR Ca2+ stores by the 
inhibition of SERCA pumps with cyclopiazonic acid (CPA, 30 µM), we observed a 
decrease in whole-cell TICC activity (Figure  3.6B), suggesting that SR Ca2+ release is 
still necessary for activation of TRPM4 channels under these conditions.  Consistent 
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with our previous report (55), inhibition of ryanodine receptors by ryanodine (50 µM) had 
no effect (Figure  3.6D), while blocking IP3R with Xestospongin C (1 µM) greatly 
attenuated whole-cell TICC activity (Figure  3.6C). To further characterize the role of 
IP3R, we employed the membrane permeable IP3 analog, Bt-IP3 (200) to activate IP3R.  
We observed a dose-dependent increase in TICC activity in the presence of Bt-IP3 
(Figure  3.6E), which was blocked in the presence of Xestospongin C. These data 
provide additional evidence for the activation of TRPM4 by Ca2+ released from IP3R. 
Overall, these findings suggest that inclusion of EGTA (10 mM) in the pipette solution 
does not disrupt activation of TRPM4 by IP3R-mediated Ca
2+ release but does provide 
sufficient buffering capacity to prevent rapid Ca2+-dependent inactivation of the channel. 
 
Whole-Cell TICC Activity is Modulated by the Cytosolic Buffering with BAPTA. 
Our findings show that the activation of plasma membrane TRPM4 channels by 
Ca2+ released from IP3Rs on the SR membrane is not blocked when EGTA (10 mM) is 
included in the intracellular solution, suggesting that the two channels are in close 
proximity.  The effectiveness of Ca2+ buffers within a given volume is dependent on the 
Ca2+ affinity, binding rates, and mobility of the buffer (112).  EGTA and BAPTA have 
similar mobility and steady-state binding affinities for Ca2+ (Table 1) and differ only in 
the binding kinetics, i.e. BAPTA binds Ca2+ approximately 100 times faster than EGTA 
(116).  Comparing the buffering effectiveness of BAPTA versus an identical 
concentration of EGTA has previously been used to estimate the volume buffered within 
the range of tens of nanometers (46, 116).  To further characterize the Ca2+ domains 
between IP3Rs and TRPM4, we modeled the effects of different concentrations of 
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BAPTA on the linear spread of Ca2+ released from a single IP3R, as described above.  
We used buffering parameters previously reported for the diffusion coefficient, Ca2+ 
affinity, dissociation constant, and Ca2+ on- and off-rates for BAPTA (Table 1) (112).  
With an intracellular [BAPTA] of 0.1 mM, our model predicts that the spatial spread of 
Ca2+ from a point source will be nearly identical to that of an endogenous buffering 
environment, whereas when [BAPTA] was increased to 10 mM, our model predicts that 
the spatial spread of Ca2+ is much more restricted (Figure  3.7).      
To test the predictions of our cytosolic Ca2+ buffering model we examined Ca2+-
dependent activation and inactivation of TRPM4 channel activity. Different 
concentrations of EGTA and BAPTA were included in the pipette solution, and whole-
cell TICC activity was recorded from freshly isolated cerebral artery myocytes.  A 
graphical representation of the hypothesized effects of these buffering conditions on 
Ca2+ levels at the plasma membrane and TRPM4 activity is shown in Figure  3.8B. We 
found that when EGTA (10 mM) and BAPTA (0.1 mM), which emulate the effects of 
endogenous Ca2+ buffering (Figure  3.8B), were included in the pipette solution, whole-
cell TICC activity did not differ from that observed when cells were patch clamped under 
perforated patch conditions (Figure  3.8A).  When EGTA was included in the patch 
pipette at concentrations lower than 10 mM, whole-cell TICC activity was significantly 
less than that recorded under perforated patch conditions (Figure  3.8A), suggesting 
that buffering under these conditions was insufficient to prevent Ca2+-dependent 
inactivation of TRPM4 channel activity (Figure  3.8B).  Inclusion of BAPTA at 1 or 10mM 
diminished channel activity (Figure  3.8A), suggesting that TRPM4 channels are located 
very near to, but are not physically coupled with IP3Rs (2, 3).  Our model predicts that 
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the spatial spread of Ca2+ is restricted under these conditions (Figure  3.8B), suggesting 
that Ca2+ levels within the plasma membrane and SR junctions are insufficient to 
activate channel activity.  These data demonstrate, in agreement with our modeling 
predictions, that EGTA (10 mM) and BAPTA (0.1 mM) are sufficient to restore 
endogenous Ca2+ buffering lost during cellular dialysis under whole cell patch clamp 
conditions and can prevent rapid Ca2+-dependent inactivation of the channel.  
 
TRPM4 and IP3R are Proximate. 
Our functional electrophysiological data suggest that the activation of plasma 
membrane TRPM4 channels by Ca2+ released from IP3Rs on the SR membrane 
requires that the two channels and membranes be in close proximity. To test this idea 
and assess the relative localization of TRPM4 and IP3R in cerebral artery myocytes, 
isolated cells were immunolabeled with TRPM4 and IP3R-specific antibodies, and the 
SR and plasma membranes were fluorescently stained with selective dyes. In cells 
stained with selective dyes, the SR membrane is plainly visible and is clearly separated 
from the plasma membrane, demonstrating dye specificity and the close proximity of the 
two membranes (Figure  3.9A, insert a).  Separation of the SR membrane from the 
plasma membrane is apparent in intensity plots along a line segment as distinct 
fluorescence peaks corresponding to the plasma (red) and SR (green) membranes 
(Figure  3.9A, insert b). When immunolabeling and membrane staining are combined, 
we observe that TRPM4 channels are localized to the plasma membrane, and IP3Rs 
are expressed in the SR membrane approaching the plasma membrane (Figure  3.9B-
E).  Dual immunolabeling experiments confirm the proximal localization of TRPM4 
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channels and IP3R at distinct junction sites (Figure  3.9F, inserts a and b).  These 
findings demonstrate the presence of SR to plasma membrane (SR/PM) junctions 
where IP3R channels are present in the SR membrane proximal to TRPM4 channels 
localized in the plasma membrane.       
DISCUSSION 
The current study demonstrates the importance of endogenous intracellular Ca2+ 
buffering for maintaining TRPM4 activity in cerebral artery myocytes.  Our major 
findings are: (1) restoration of endogenous Ca2+ buffering capacity lost when native 
smooth muscle cells are dialyzed under conventional whole cell conditions prevents 
time-dependent inactivation of whole-cell TICCs; (2)  the biophysical properties of 
whole-cell TICCs are consistent with those of TICCs recorded using the perforated 
patch clamp configuration and TRPM4 currents recorded using conventional methods; 
(3) the pharmacological and molecular profile of currents recorded under whole-cell 
conditions indicates that these novel currents are conducted by TRPM4 channels; and 
(4) high concentrations of BAPTA can extinguish the Ca2+ signaling required for the 
activation of TRPM4, suggesting that TRPM4 channels are not physically coupled to 
IP3R but are located within 50 nm.  These findings demonstrate for the first time that 
cytosolic Ca2+ buffering influences membrane excitability by maintaining and modulating 
TRPM4 channel activity in native cerebral artery smooth muscle cells.  
Many of the biophysical and pharmacological characteristics of the novel whole-
cell TICCs reported here are identical to those we previously reported for TICCs 
recorded under perforated patch clamp conditions (55), and those described for TRPM4 
channels recorded under conventional patch clamp conditions.  For example, whole-cell 
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TICCs recorded from native cerebral artery myocytes have the same frequency of 
occurrence (20.1 ± 2.0 Hz, n = 5) as TICCs recoded under perforated patch clamp 
conditions (20.1 ± 1.7 Hz, n = 5) and are in agreement with the reported unitary 
conductance of TRPM4 (134, 138, 199).  Whole-cell TICCs reversed at a membrane 
potential near 0 mV in symmetrical cationic solutions and substitution of Na+ with the 
impermeant cation NMDG in the bathing solution completely blocked channel activity, 
consistent with TRPM4’s selectivity for monovalent cations (40, 128).   We also found 
that whole-cell TICC activity was significantly less following administration of TRPM4 
blockers, including the selective compound 9-phenanthrol (55, 58, 60), and in cells 
isolated from arteries treated with TRPM4-specific siRNA.  Thus, we conclude that 
TICCs recorded under our whole cell conditions represent authentic TRPM4 activity in 
native cerebral artery myocytes.  
The current findings indicate that the I/V relationship of TRPM4 is strongly 
influenced by the patch clamp configuration. Single channel recordings for TRPM4 
obtained from inside-out patches in symmetrical cation solutions have a linear current to 
voltage relationship (43), while currents obtained using the conventional whole-cell 
configuration with similar solutions are dually rectifying (40, 128).  In our previous work, 
we reported that under perforated patch clamp conditions with physiological bathing 
solution, TICCs exhibited modest inward rectification at negative potentials and a small 
non-rectifying outward current at positive potentials (55).  In the current study, whole-
cell TICC activity exhibits dual rectification, similar to that observed under conventional 
whole cell recording conditions.  These discrepancies are likely a result of cellular 
dialysis. TRPM4 currents are blocked by the endogenous polyamine spermine (133), 
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which is removed by dialysis under whole cell conditions.  Polyamine block is 
responsible for rectification of inwardly-rectifying K+ (KIR) channels in vascular smooth 
muscle cells (135, 175), and we propose that this effect accounts for TRPM4 current 
rectification under native conditions.  
TRPM4 activity is necessary for pressure-induced smooth muscle 
vasoconstriction  in vitro (40, 43, 58) and autoregulation of cerebral blood flow in vivo 
(151), demonstrating that the channel is a critical mediator of vascular function. 
However, rapid Ca2+-dependent desensitization of TRPM4 currents when recorded 
under conventional whole cell and inside-out patch clamp conditions hindered our 
understanding of the regulatory mechanisms of the channel under native conditions.  
TRPM4 activity can be prolonged by inhibition of PLC or by inclusion of the PIP2 in the 
intracellular solution (126, 202).  These findings suggest that high intracellular 
Ca2+levels (10-100 µM) typically used to initiate and record TRPM4 current in 
conventional whole cell and inside-out configurations activates a Ca2+-dependent PLC 
isoform, leading to TRPM4 inactivation by depleting PIP2 levels. Additionally, TRPM4 
activity does not inactivate when recorded under perforated patch clamp conditions 
when the cytosolic environment is maintained (55, 71).  In the current study, we 
investigated the role of endogenous Ca2+ buffering in this process and found that when 
Ca2+ buffers are not present in the intracellular solution, whole-cell TICCs exhibit time-
dependent inactivation with kinetics similar to those observed for TRPM4-expressing 
cultured cells patch clamped using the whole cell configuration and with 100 µM free 
Ca2+ included in the intracellular solution (Figure  3.1). We hypothesized that when 
endogenous free Ca2+ buffering mechanisms are disrupted during cell dialysis under 
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conventional whole cell conditions, increases in cytosolic [Ca2+] resulting from intrinsic 
Ca2+ influx or release from the SR can also cause Ca2+-dependent inactivation of 
TRPM4. To test this possibility, we modeled the effects of endogenous Ca2+ buffers on 
the spatial spread of Ca2+ from a point source. The endogenous and exogenous 
buffering parameters used for our model are based on values reported in the literature, 
which have a wide range and may over- or under-estimate buffering capacity.  
Additionally, the model is based on buffering parameters for whole cell conditions, which 
may differ from those within specific subcellular nano or microdomains. Lastly, as a first 
order approximation, we only considered the endogenous buffering parameters of the 
most abundant Ca2+ binding protein, calmodulin, at a total intracellular concentration of 
40 µM (159, 203).  However, even with the possible inaccuracies of our model, we were 
able to accurately predict that addition of 10 mM EGTA or 0.1 mM BAPTA to the 
intracellular solution restores TRPM4 activity to that observed under native Ca2+ 
buffering conditions in the perforated patch configuration. Thus, these findings suggest 
that levels of calmodulin, and perhaps other Ca2+-binding proteins like calpain and 
troponin C, together would equal a buffering capacity similar to 10 mM EGTA.  
Furthermore, if only free Ca2+ binding proteins are lost during cellular dialysis under 
whole cell conditions, our findings suggest that anchored Ca2+ homeostasis-important 
ion channels like PMCA, Na+/Ca2+ exchangers, and SERCA pumps play a minor role in 
preventing the Ca2+-dependent inactivation of TRPM4 channels under physiological 
conditions.  Additionally, physical interaction of calmodulin with the c-terminus of 
TRPM4 is essential for Ca2+ sensitivity and activation of the channel in physiological 
range of intracellular Ca2+ concentrations (131).  Our ability to rescue channel activity 
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following cell dialysis suggests that calmodulin required for channel activation is 
constitutively bound to the channel itself and not free within the cytoplasm. This is 
consistent with work from Nilius et al., reporting five possible Ca2+-dependent 
calmodulin interacting domains on TRPM4, two at the n-terminus and three at the c-
terminus (131).  Our findings clearly demonstrate that maintenance of TRPM4 activity is 
a novel role for free endogenous Ca2+ buffering proteins, a property that may regulate 
critical features of smooth muscle cell excitability and contractility.   
Proper maintenance of SR Ca2+ stores is necessary for many cellular functions.  
SERCA pumps actively siphon Ca2+ from the cytoplasm back into the SR lumen, refilling 
internal Ca2+ stores.  This process of recycling Ca2+ is important for maintaining the 
transmembrane Ca2+ gradient of low cytosolic and high SR lumen Ca2+ levels.  Inhibition 
of the SERCA pumps by CPA disrupts the Ca2+ refilling of the SR, and Ca2+ is leaked 
from internal stores into the cytoplasm, disrupting the Ca2+ gradient.  In many types of 
cells, SR Ca2+ store depletion activates store operated Ca2+ entry channels (SOCs) 
(146).  However, in the current study, we did not record SOC activity following the 
depletion of internal Ca2+ stores with CPA.  This observation is consistent with prior 
studies that failed to demonstrate SOC activity in contractile cerebral artery smooth 
muscle cells (87, 147, 158, 197, 200).  Consistent with our previous reports using 
perforated patch clamp (55), whole-cell TICC activity quickly decreased following the 
pharmacological inhibition of SERCA pumps by CPA (30 µM).  It seems likely that 
depletion of SR Ca2+ stores translates to a loss of Ca2+ release and decreased 
activation of Ca2+-sensitive ion channels.  For example, the large conductance Ca2+-
activated potassium channel (BKCa) is stimulated by Ca
2+ release from ryanodine 
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receptors located on the SR membrane to produce spontaneous transient outward 
currents (STOCs) (79, 121).  Store depletion significantly decreases Ca2+ dependent 
activation of BKCa channels and STOC activity is abolished within 40-120 seconds 
following CPA administration (20, 170, 179).  Thus, the time required for BKCa 
inactivation in response to CPA is similar to that observed for TRPM4 inactivation 
following this treatment in the current study, suggesting that loss of TRPM4 activity 
results from diminished SR Ca2+-release. Alternatively, it is possible that CPA-induced 
Ca2+ leak from internal stores elevates [Ca2+] within small cytoplasmic spaces proximal 
to the plasma membrane to levels that lead to Ca2+-dependent inactivation of TRPM4 
channels.  Consistent with this possibility, reports using fluorescent Ca2+ indicators in 
smooth muscle cells show an immediate increase in cytosolic Ca2+, presumably due to 
Ca2+ leak from the SR, reaching maximum [Ca2+]i within 40 - 300 seconds (65, 80).  
This subsequent increase in global calcium may lead to TRPM4 channel inactivation 
and the relative rapid loss of TICC activity.  Regardless of the exact mechanisms, our 
findings clearly show that intact SR Ca2+ stores are required for TRPM4 activity in native 
cerebral artery myocytes. 
Differential modulation of TRPM4 channel activity by the slow Ca2+ buffer EGTA 
and the fast Ca2+ buffer BAPTA provides strong evidence that TRPM4 channels are 
proximal and functionally coupled with IP3R through Ca
2+ signaling events.  BAPTA and 
EGTA have similar steady-state Ca2+ binding affinities, but significantly different binding 
rate constants (Table 1) (5).  Based on this divergence, comparison of BAPTA- and 
EGTA-dependent disruptions of Ca2+-dependent processes can be used to classify 
localized regions of elevated Ca2+  as “Ca2+ nanodomains” or “Ca2+ microdomains” (7, 
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46, 116).  Ca2+ microdomains, with a Ca2+ source-to-sensor distance of greater than 50 
nm, are defined by Ca2+-dependent responses that are equally disrupted by identical 
concentrations of BAPTA and EGTA (7, 116).  In contrast, Ca2+ nanodomains, with a 
Ca2+ source-to-sensor distance less than 50 nm, are defined by Ca2+-dependent 
responses that are significantly interfered with by BAPTA, but not by equal 
concentrations of EGTA (7, 116). Our findings demonstrating that whole-cell TICC 
activity can be recorded in the presence of 10 mM EGTA but not in 10 mM BAPTA 
suggest that IP3R-mediated activation of TRPM4 channels occur in Ca
2+ nanodomains, 
and that TRPM4 channels and IP3R are less than 50 nm apart.    The current estimate 
of the junctional spaces between plasma membrane caveolae and SR membrane 
projections is 15 ± 7 nm (53, 145).   Therefore, our findings suggest that IP3R and 
TRPM4 channels are localized within these small spaces.  Additionally, recent studies 
have reported physical coupling of IP3R and the canonical TRP channel, TRPC3, 
through the caveolae scaffolding protein caveolin-1 in smooth muscle cells (2, 3, 200).  
Inhbition of whole-cell TICCs by Ca2+ chelation with BAPTA provides 
electrophysiological evidence that plasma membrane TRPM4 channels are not 
physically coupled to IP3R located in the SR, but rather are activated by Ca
2+ release 
events from IP3R located less than 50 nm away from TRPM4 channels on the plasma 
membrane.   
In conclusion, our findings suggest that endogenous intracellular Ca2+ buffering 
and SR Ca2+ recycling are essential for maintenance of TRPM4 channels activity in 
cerebral artery smooth muscle cells.  Furthermore, we demonstrate that IP3R-mediated 
activation of TRPM4 channels occur within Ca2+ nanodomains created by SR/plasma 
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membrane junctions. Lastly, the regulation of smooth muscle cytosolic Ca2+ buffering 
and the SR/plasma membrane architecture play integral roles in excitability and arterial 








  Figure 3.1: The Kinetics of Ca2+-Dependent TRPM4 Desensitization are Similar in 
A7r5 and Freshly Isolated Smooth Muscle Cells.  A: Current/Voltage (I/V) relationship 
showing total current at 8 (grey arrowhead) and 60 seconds (white arrowhead) after 
peak (black arrowhead) in A7r5 cells expressing TRPM4-GFP and non-transfected 
cells (*). Cells were recorded under conventional whole cell patch clamp conditions 
(WC) with 100 µM Ca2+ added to the pipette solution. B: Representative trace of 
Transient Inward Cation Currents (TICC) activity recorded from a freshly isolated 
cerebral artery smooth muscle cell (SMC) under perforated whole cell patch clamp 
conditions (PP).  Membrane potential = -70 mV.  C: Representative trace of TICC-like 
activity recorded from a freshly isolated cerebral artery smooth muscle cell under 
conventional whole cell patch clamp conditions when no Ca2+ buffer is present in the 
intracellular solution.  Membrane potential = -70 mV.  D: Time course of inactivation 
of TRPM4 currents (at +70 mV) in A7r5 cells (n=6), TICC activity recorded under 
perforated patch clamp conditions (n=8), and TICC-like currents recorded under 
whole-cell conditions in native myocytes (n=5) as a fraction of the peak current 
following cellular dialysis. 
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Table 3.1. Modeling Buffering Parameters 
Parameters Endogenous BAPTA EGTA 
Diffusion Coefficient (µm2s-1) 20 220 200 
Ca2+ affinity (Kd) (nM) 200 150 150 
Dissociation constant βF/αF (µM) 10 0.22 0.15 
Ca2+ On-rate αF (µM
-1s-1) 1 400 5 
Ca2+ Off-rate βF (s
-1) 10 80 0.75 
 




Figure 3.2: Endogenous Ca2+ Buffering Can be Mimicked with EGTA.    Modeling the 
effects of endogenous buffering capacity and different concentrations (1 and 10 mM) 
of the slow Ca2+ chelator EGTA on [Ca2+] as a function of distance from a single IP3R 





Figure 3.3: Sustained Transient Cation Channel Activity in Freshly Isolated Smooth 
Muscle Cells.  A: Representative perforated patch clamp recordings of Transient 
Inward Cation Currents (TICC) obtained using the amphotericin B perforated patch 
configuration.  Representative of 5 cells.  Insert shows expanded time scale.   B: 
Peak amplitude histogram of TICC activity recorded from freshly isolated smooth 
muscle (0.1 pA bins) under perforated patch clamp conditions.  Data are fitted with 
multiple Gaussian functions.  The solid-line peaks match calculated current amplitude 
for TRPM4 channel openings. The dash-line peaks do not match with calculated 
current amplitude for TRPM4 channel openings. C: Representative conventional 
whole cell patch clamp recording of whole-cell TICC activity with 10 mM EGTA 
included in the pipette solution. D: Peak amplitude histogram of whole-cell TICC 
activity recorded from freshly isolated smooth muscle (0.1 pA bins) with 10 mM 
EGTA in the pipette solution.  Data are fitted with multiple Gaussian functions, with 
the solid-line and dash-line peaks matching and not matching, respectively, with the 





Figure 3.4: Biophysical Properties of Whole-Cell TICC Activity.  A: Representative 
trace and summary data of whole-cell TICC activity in the presence of the 
tetraethylammonium (TEA) (10 mM, n=4).  B: Representative trace and summary 
data of whole-cell TICC activity with Na+ replaced with the non-permeabale cation N-
methyl-D-glucamine (NMDG), n=9, *P≤0.05 vs. Control. C: Sample traces of whole-
cell TICC recordings obtained at holding potentials (VH) from +80 to -70 mV in the 
presence of TEA.  Average current amplitude to voltage relationship (I/V) for cells 





  Figure 3.5: Whole-Cell TICCs Represent TRPM4 Channel Activity. A: Representative 
trace and summary data of whole-cell TICC activity in the presence of fluflenamic 
acid (10 µM, n=3), a blocker of TRPM4 activity.  B: Representative traces and 
summary data of whole-cell TICC activity in the presence of the selective TRPM4 
blocker 9-phenanthrol (30 µM, n=3). *P≤0.05 vs. control. C: Representative 
recordings and summary data of whole-cell TICC activity from a cell isolated from 
arteries treated with control (top; n=10) and TRPM4 (bottom n=10) siRNA.  *P≤0.05 







Figure 3.6: Whole-Cell TICCs are Activated by IP3R-dependent SR Ca
2+ Release. A: 
Representative trace and summary data of whole-cell TICC activity in the presence of 
extracellular Ca2+ (n=4) and at 45 sec [1] (n=4) and ~3 minutes [2] (n=3) after 
extracellular Ca2+ is removed.  B: Representative trace and summary data of whole-
cell TICC activity in the presence of the SERCA pump blocker cyclopiazonic acid 
(CPA, 30 µM, n=3).  C: Representative trace and summary data of whole-cell TICC 
activity in the presence of the specific ryanodine receptor blocker ryanodine (50 µM, 
n=3). D: Representative trace and summary data of whole-cell TICC activity in the 
presence of the specific IP3R blocker Xestospongin C (1 µM, n=3). *P≤0.05 vs. 
control. E: Representative trace and dose response of the effects of the membrane 
permeable IP3 analog, Bt-IP3 (10 µM) on whole-cell TICC activity (EC50 = 1.6 µM); n = 
3-5 per dose. F: Representative trace and summary data of whole-cell TICC activity 
in the presence of Xestospongin C (1 µM, n=3), and Bt-IP3 (10 µM, n=4). *P≤0.05 vs. 






Figure 3.7: Endogenous Ca2+ Buffering Can be Mimicked with BAPTA.    Modeling 
the effects of endogenous buffering capacity and different concentrations (0.1 and 10 
mM) of the fast Ca2+ chelator BAPTA on [Ca2+] as a function of distance from a single 
IP3R Ca





Figure 3.8: Effects of Buffer Concentration on Whole-Cell TICC Activity. A: 
Representative traces of channel activity from recordings under perforated patch 
clamp (PP) and whole-cell configuration with different concentration of EGTA or 
BAPTA added to the pipette solution. B: Summary data showing average total open 
probabilities (NPo) of whole-cell TICC activity at different concentrations of Ca
2+ 
buffers; n = 5-7 per group. *P≤0.05 vs. PP, #P≤0.05 vs. 10 mM EGTA, and †P≤0.05 
vs. 0.1 mM BAPTA. C: Schematic representation of the Ca2+ spread and hypothetical 









Figure 3.9: Localization of TRPM4 and IP3R in Freshly Isolated Smooth Muscle 
Cells. A: Representative images demonstrate the specific fluorescent staining of the 
sarcoplasmic reticulum (SR, green) and plasma membrane (red) in a freshly isolated 
smooth muscle cell. Merged image shows little overlap of the SR and plasma 
membrane. Bar = 5 µm. (a) Higher magnification of insert illustrating specific staining 
of SR and plasma membrane. (b) Intensity profile of SR and plasma membrane 
fluorescence along the line segment. B: Representative images of an isolated smooth 
muscle cell immunolabeled for TRPM4 (green) and stained for the plasma membrane 
(red). Bar = 10 µm.  Bottom: High magnification insert demonstrating the co-
localization (yellow) of TRPM4 with the plasma membrane.  C: Representative 
images of an isolated smooth muscle cell immunolabeled for TRPM4 (green) and 
stained for the SR membrane (red). Bar = 10 µm.  Bottom: High magnification insert 
demonstrating separation of TRPM4 and the SR membrane.  D: Representative 
images of an isolated smooth muscle cell immunolabeled for IP3R (green) and 
stained for the plasma membrane (red). Bar = 10 µm.  Bottom: High magnification 
insert demonstrating separation of IP3R and the plasma membrane.  E: 
Representative images of an isolated smooth muscle cell immunolabeled for IP3R 
(green) and stained for the SR membrane (red) Bar = 10 µm.  Bottom: High 
magnification insert demonstrating the co-localization of IP3R with the SR membrane 
(yellow). F:  Representative images of an isolated smooth muscle cell immunolabeled 
for IP3R (green) and TRPM4 (red).  Bar = 10 µm.  (a and b) High magnification of 
inserts illustrating specific localization of TRPM4 (red, outside) and IP3R (green, 









 Smooth muscle cell membrane potential is central to the regulation of arterial 
tone. Receptor-dependent vasoconstrictor agonists and intraluminal pressure 
depolarize vascular smooth muscle and open voltage-dependent Ca2+ channels 
(VDCCs), causing intracellular [Ca2+] to rise and contractility to increase. The resting 
membrane potential of arterial myocytes is established by the relative magnitude of 
hyperpolarizing and depolarizing influences. K+ efflux tend to drive the membrane 
potential to the K+ equilibrium potential (EK at 37ºC ≈ -90 mV) (68, 121) whereas cation 
influx directs the membrane to depolarized potentials (ENa at 37ºC ≈ +60 mV, ECa2+ ≈ 
+150 mV) (68, 121). K+ channel-dependent hyperpolarization of smooth muscle 
membrane potential has been studied extensively (121) but much less in known about 
the cation channels that contribute to membrane depolarization.  
Several members of the transient receptor potential (TRP) superfamily of cation 
channels are present in vascular smooth muscle cells and contribute to the regulation of  
smooth muscle membrane potential and contractility (36, 40, 43, 151, 152, 194).  
Antisense-mediated gene silencing has been used to demonstrate that expression of 
TRPM4 (39, 40, 151) and TRPC6 (194) channels are required for pressure-induced 
smooth muscle cell depolarization and myogenic vasoconstriction of cerebral arteries. 
TRPC3 channels mediate receptor-dependent responses in these vessels(152). Further 
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investigation into the regulation of TRP channels and how they influence vascular 
function has been hampered by the lack of selective pharmacological inhibitors. 
Recently, it was reported that the hydroxytricyclic compound 9-hydroxyphenanthrene (9-
phenanthrol) blocks TRPM4 channels in an HEK cell expression system with a half-
maximal inhibitory concentration (IC50) of 16.7±4.5 µM under conventional whole-cell 
patch clamp conditions (60). The related channel TRPM5 is not inhibited by 9-
phenanthrol at a concentration of 100 µM, suggesting that the compound has selectivity 
for TRPM4 (60). However, the effects of the compound on other TRP, K+, and Ca2+ 
channels involved in smooth muscle cell function have not been previously reported. 
Therefore, the goals of the current study were to further examine the selectivity of 9-
phenanthrol and to determine the effects of the compound on cerebral artery smooth 
muscle cell membrane potential and contractility. 
 We find that 9-phenanthrol blocks sustained TRPM4 currents in freshly isolated 
cerebral artery myocytes with an IC50 that is consistent with the value reported for 
recombinant TRPM4 channels expressed in HEK cells. In addition, we find that 9-
phenanthrol is without effect on TRPC3 and TRPC6 currents in HEK expression 
systems. Our studies also demonstrate that 9-phenanthrol is without effect on K+ and 
VDCCs that are involved in the regulation of smooth muscle membrane potential and 
contractility, suggesting that the compound may be useful for investigation of the 
physiological function of TRPM4 in these cells. Block of TRPM4 currents with 9-
phenantrol in intact cerebral vessels at physiological intraluminal pressure results in 
substantial hyperpolarization of vascular smooth muscle cell membrane potential and 
dilation of arteries with myogenic tone. These findings show that TRPM4 currents play a 
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major role in establishing the membrane potential of arterial myocytes and maintaining 
myogenic tone.  
 
MATERIALS AND METHODS 
Animals 
Male Sprague-Dawley rats (300-350 g; Harlan, Indianapolis, Indiana, USA) were 
used for these studies. Animals were deeply anesthetized with sodium pentobarbital (50 
mg/kg. i.p.) and euthanized by exsanguination according to a protocol approved by the 
Institutional Animal Care and Use Committee (IACUC) of Colorado State University. 
Brains were isolated in ice-cold MOPS-buffered saline (in mM): 3 MOPS (pH 7.4), 145 
NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 2 pyruvate, 5 glucose and 1% 
bovine serum albumin. Cerebral and cerebellar arteries were dissected from the brain, 
cleaned of connective tissue, and stored in MOPS-buffered saline on ice prior to further 
manipulation.  
 
Cerebral Artery Smooth Muscle Cell Preparation  
To isolate smooth muscle cells, vessels were cut into 2-mm segments and placed 
in the following Mg2+-based physiological saline solution (Mg-PSS) (in mM): 140 NaCl, 
5 KCl, 2 MgCl2, 10 glucose, and 10 HEPES;
 (pH 7.2). Arterial segments were initially 
incubated at room temperature in 0.6 mg/mL papain (Worthington) and 1 mg/ml 
dithiothreitol (DTT) for 17 min, followed by a 15 min incubation at 37 ºC in 1 mg/mL type 
II collagenase (Worthington). Digested segments were washed three times in Mg-PSS 
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and triturated to release smooth muscle cells. Cells were stored on ice in Mg-PSS for 
use the same day.  
 
Human Embryonic Kidney (HEK) Cell Culture  
Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco’s 1X High 
Glucoses Modified Eagle Medium (Gibco) supplemented with 10% fetal bovine serum 
(Gibco) and 0.5% penicillin-streptomycin (Gibco).  Cells were incubated at 37C with 6% 
CO2, media was changed every 2-3 days, and cells were sub-cultured when confluent 
using 0.25% Trypsin-EDTA (Gibco).  
 
General Patch Clamp Electrophysiology 
Currents were recorded using an AxoPatch 200B amplifier equipped with an 
Axon CV 203BU headstage (Molecular Devices). Recording electrodes (1-3 MΩ) were 
pulled, polished, and coated with wax to reduce capacitance.  GΩ seals were obtained 
in Mg-PSS. Currents were filtered at 1 kHz, digitized at 40 kHz, and stored for 
subsequent analysis.  Clampex and Clampfit versions 10.2 (Molecular Devices) were 
used for data acquisition and analysis, respectively. All patch clamp experiments were 
performed at room temperature (22 - 25°C). 
 
TRPC3 and TRPC6 Currents in HEK Cells  
The pipette solution used to record both TRPC3 and TRPC6 currents contained 
(mM) 130 CsOH, 110 aspartic acid, 15 CsCl, 1 MgCl2, 3.6 CaCl2, 10 EGTA, 10 HEPES 
(pH 7.4).  The extracellular bath solution for TRPC3 contained (mM) 140 NaCl, 5 CsCl, 
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0.1 MgCl2, 0.05 CaCl2, 10 Glucose, 10 HEPES (pH 7.4).  HEK cells were co-transfected 
by electroporation with a plasmid that encodes TRPC3 channels tagged with Yellow 
Fluorescent Protein (TRPC3-YFP) and with a second plasmid encoding the 
Angiotension II (AngII) AT1 receptor.  Transfected cells were plated on 12 mm glass 
cover slips and allowed to adhere for ~2-3 hours at 37C, 6% CO2.  Transfected cells 
expressing TRPC3-YFP were identified using fluorescent microscopy, initially voltage 
clamped at 0 mV, and voltage ramps from -100 mV to +100 mV were applied every 4 
seconds. After baseline currents were recorded, AngII (10 nM) was administered to 
induce receptor-mediated TRPC3 currents. When the evoked current reached a steady 
state, 9-phenanthrol (30 M) was administered to examine the effect of the compound 
on TRPC3 currents.  
The extracellular bath solution used to record TRPC6 currents contained (in mM) 
150 NaCl, 0.08 KCl, 0.8 MgCl2, 5.4 CaCl2, 10 Glucose, 10 HEPES (pH 7.4).  HEK cells 
transiently transfected with a TRPC6 expression plasmid (ChanTest, Inc.) and non-
transfected cells were plated on glass cover slips and allowed to adhere for ~12 hours 
at 37C, 6% CO2. Using the same voltage protocol used to record TRPC3 currents, 
conventional whole-cell currents were recorded from TRPC6-expressing cells and 
compared to currents recorded from non-transfected cells. 9-phenanthrol (30 M) was 
administered to TRPC6-expressing cells to assess the effects of the compound on 
TRPC6 currents.  
The calculated reversal potential for monovalent cations is 0 mV for the TRPC3 
solutions and 0.9 mV for the TRPC6 solutions.  For divalent cations, the reversal 
potentials are -43.2 mV for the TRPC3 solutions and 3.8 mV for the TRPC6 solution.  
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Reversal potentials for monovalent anions are 1.6 mV for the TRPC3 solution and -1 
mV for the TRPC6 solution.  
 
Large conductance Ca2+-activated K+ (BKCa) and TRPM4 Currents in Smooth Muscle 
Cells  
Spontaneous transient outward currents (STOCs) result from activation of 
numerous BKCa channels following transient release of Ca
2+ from ryanodine receptors 
located on the sarcoplasmic reticulum (SR) and represent BKCa activity under 
physiological conditions in smooth muscle cells (118). Transient inward cation currents 
(TICCs) are the result of activation of TRPM4 channels by SR Ca2+ released from 
inositol trisphosphate receptors (IP3R) (54). For the current study, both STOCs and 
TICCs were recorded using the perforated patch clamp configuration. Isolated smooth 
muscle cells were transferred to a recording chamber (Warner Instruments) and allowed 
to adhere to glass coverslips for 20 min at room temperature.  Amphotericin B (40 µM) 
was included in the pipette solution to perforate the membrane.  Acceptable perforation 
was determined by a series resistance of less than 50 MΩ.  STOCs and TICC activity 
were recorded in normal external bathing solution containing (in mM) 134 NaCl, 6 KCl, 1 
MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose at pH of 7.4 (NaOH).  The pipette solution 
contained (in mM) 110 K-aspartate, 1 MgCl2, 30 KCl, 10 NaCl, 10 HEPES, 5 (µM) 
EGTA at pH 7.2 (NaOH).    STOCs were recorded at a membrane potential of +20 mV 
and TICCs were recorded at -70 mV. The calculated reversal membrane potential for 
the perforated patch solutions is is -1.8 mV for total monovalent cations and -30.6 mV 
for monovalent anions (Cl-). STOCs were defined as a transient event greater than 10 
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pA (more than one BKCa channel), and the frequency was calculated by dividing the 
number of events by the time between the first and last event.  TICC activity at -70 mV 
was calculated as the sum of the open channel probability (NPo) of multiple open states 
of 1.75 pA. This value was based on the reported unitary conductance of TRPM4 (25 
pS).   









 1  
Where: 
tj = time spent in seconds with j = 1,2,….N channels open 
N = max number of channels observed  
T = duration of measurement. 
 
Voltage-Dependent K+ (KV) Currents in Smooth Muscle Cells  
The conventional whole-cell patch clamp configuration was used to examine the 
effects of 9-phenanthrol on Kv currents in smooth muscle cells.  The extracellular bath 
solution contained (mM) 5 KCl, 140 NaCl, 2 MgCl2, 10 Glucose, and 10 HEPES.   The 
pipette solution contained (mM) 87 K+ aspartate, 20 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 
10 EGTA, and 5 MgATP. Cells were initially voltage clamped at -80 mV and voltage 
steps from -80 mV to +30 mV were applied for 400 ms in 10 mV increments, followed 
with a step to -40 mV for 200 ms.  Recordings were performed in the presence of 
paxilline (5 µM) to block BKCa activity.  Recording were obtained in the presence of the 
vehicle for 9-phenanthrol (DMSO) and when 9-phenanthrol (30 µM) was present in the 
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superfusion bath.  Average current density (pA/pF) during the steady state for each 
voltage step was used to generate current-voltage relationships.   
 
Inwardly-Rectifying (KIR) Currents in Smooth Muscle Cells   
Conventional patch-clamp electrophysiology was used to measure whole-cell KIR 
currents in isolated smooth muscle cells using a previously described method (172). 
The pipette solution for these experiments contained (mM): 5 NaCl, 35 KCl, 100 K+ 
gluconate, 1 CaCl2, 10 HEPES, 10 EGTA, 2.5 Tris-ATP and 0.2 GTP (pH 7.2). Cells 
were voltage clamped at −60 mV and equilibrated for 15 min in a bath solution 
containing (mM): 135 NaCl, 5 KCl, 0.1 MgCl2, 10 HEPES, 5 glucose and 0.1 CaCl2 (pH 
7.4). Following equilibration, bath [K+] was elevated from 5 to 60 mM by replacement of 
NaCl by KCl. Voltage ramp between −120 and 20 mV (0.047 mV ms−1) were applied in 
the presence and absence of 30 μM BaCl, and KIR (Ba
2+-sensitive) currents were 
calculated by current subtraction. KIR currents recorded in the presence of 9-
phenanthrol were compared to those recorded in the presence of vehicle (DMSO). 
Voltage-Dependent Ca2+ Currents in Smooth Muscle Cells The conventional whole-cell 
patch clamp technique was used to record VDCCs in smooth muscle cells. Freshly 
prepared cerebral arterial myocyte suspensions were transferred to a recording 
chamber and the cells were allowed to adhere to glass cover slips for 20 minutes at 
room temperature. During experiments, cells were superfused with a solution containing 
(in mM): 120 NMDG+, 5 CsCl, 1 MgCl2, 10, glucose, 10 HEPES, and 20 CaCl2 adjusted 
to pH 7.4 with HCl. Pipettes were filled with a solution composed of (in mM): 87 Cs-
aspartate, 20 CsCl, 1 MgCl2, 5 MgATP, 0.1 Na2GTP, 1 NADPH, 10 HEPES, and 10 
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EGTA, adjusted to pH 7.2 with CsOH. Cells were initially voltage clamped at -70 mV 
and VDCC currents were evoked by stepping the membrane potential to +30 mV. 
Currents recorded in the presence of vehicle (DMSO) were compared to those recorded 
in the presence of 9-phenanthrol (30 µM). 
 
Isolated Vessel Experiments 
Arteries were harvested and transferred to a vessel chamber (Living Systems, 
Inc.). The proximal end of the vessel was cannulated with a glass micropipette and 
secured with monofilament thread.  Blood was gently rinsed from the lumen, and the 
distal end of the vessel was cannulated and secured.  Arteries were pressurized to 10 
mmHg with physiological saline solution (PSS) (in mM): 119 NaCl, 4.7 KCl, 1.8 CaCl2, 
1.2 MgSO4, 24 NaHCO3, 0.2 KH2PO4, 10.6 glucose, 1.1 EthyleneDiamineTetraacetic 
Acid (EDTA) and superfused (5 mL/min) with warmed (37C) PSS aerated with a 
normoxic gas mixture (21% O2, 6% CO2, balance N2). Following a 15-minute 
equilibration period, intraluminal pressure was slowly increased to 110 mmHg, vessels 
were stretched to remove bends, and pressure was reduced to 10 mmHg for an 
additional 15-minute equilibration period.  Inner diameter was continuously monitored 
using video microscopy and edge-detection software (Ionoptix). Arteries pressurized to 
10 mmHg were exposed to isotonic PSS containing 60 mM KCl to assess viability of the 
preparation. Arteries were pressurized to 70 mmHg and stable myogenic tone was 
allowed to develop prior to the administration of 9-phenanthrol. To determine maximum 
(i.e. passive) diameter, vessels were superfused with Ca2+-free PSS (in mM): 119 NaCl, 
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4.7 KCl, 1.2 MgSO4, 24 NaHCO3, 0.2 KH2PO4, 10.6 glucose, 1.1 EDTA, 3 EGTA, and 
0.01 diltiazem.  
 
Smooth Muscle Cell Membrane Potential  
 For measurement of smooth muscle cell membrane potential, cerebral arteries 
were isolated and pressurized to 70 mmHg, and smooth muscle cells were impaled 
through the adventitia with glass intracellular microelectrodes (tip resistance 100-200 
M). A WPI Intra 767 amplifier was used for recording membrane potential (Em).  
Analog output from the amplifier was recorded using Ionwizard software (sample 
frequency 20 Hz).  Criteria for acceptance of Em recordings were: 1) an abrupt negative 
deflection of potential as the microelectrode was advanced into a cell; 2) stable 
membrane potential for at least 1 minute; and 3) an abrupt change in potential to 
approximately 0 mV after the electrode was retracted from the cell.  
 
Calculations and Statistics 
 All data are mean ± SE. Values of n refer to number of arteries for isolated vessel 
experiments or number of cells for patch clamp experiments. Statistical methods 
conform to the recommendations of the editors of Circulation Research(189). A level of 





9-Phenanthrol Selectively Blocks Sustained TRPM4 Currents 
A recent report from our laboratory demonstrates that TICCs, TRPM4 currents 
under near-physiological conditions, can be recorded from cerebral artery smooth 
muscle cells voltage clamped using the amphotericin B perforated patch configuration 
(54). TICC currents are diminished when TRPM4 expression is attenuated using siRNA, 
suggesting that TICCs represent TRPM4 activity under physiological conditions in 
cerebral artery smooth muscle cells (54).  To characterize the effects of 9-phenanthol 
on native TRPM4 currents, we examined the concentration-response relationship for 
TICC inhibition. We find that 9-phenanthrol inhibits TICC activity in a concentration-
dependent manner with an IC50 of 10.6 µM, (Figure  4.1A and B) in agreement with the 
prior report (16.7±4.5 µM for TRPM4 channel in an HEK expression system, whole-cell 
conditions (60)). These data indicate that 9-phenanthrol effectively blocks TRPM4 
currents recorded under near-physiological conditions in native smooth muscle cells. 
The effects of 9-phenanthrol on other ion channels involved in smooth muscle 
cell function have not been previously reported. We began our investigation into the 
specificity of the compound by examining its effects on TRPC3 and TRPC6 currents. 
These channels were selected because both are involved in the regulation of cerebral 
artery smooth muscle membrane potential and contractility (76, 152, 194).  To study the 
effects of 9-phenanthrol on TRPC3 currents, recombinant TRPC3 channels and 
angiotensin II (AngII) AT1 receptors were co-expressed in HEK cells. Transfected cells 
were patch clamped in the conventional whole-cell configuration. Currents in 
unstimulated cells were small (Figure  4.2A and B).  However, large TRPC3-dependent 
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currents were evoked by administration of AngII (10 nM) (Figure  4.2A and B). These 
currents were not diminished by administration of 9-phenanthrol (30 µM) to the bathing 
solution (Figure  4.2A and B), indicating that TRPC3 channels are not blocked by the 
compound.  
HEK cells transiently transfected with recombinant TRPC6 were also patch 
clamped in the conventional whole-cell configuration. Basal cation currents recorded 
from TRPC6-expressing cells were greater in magnitude than those recorded from 
untrasfected HEK cells (Figure  4.2C and D). 9-phenanthrol had no effect on these 
currents (Figure  4.2C and D), indicating that TRPC6 channels are not blocked by this 
compound. These experiments demonstrate that 9-phenanthrol effectively blocks 
TRPM4 channels but has no effect on TRPC3 or TRPC6 currents at a concentration 
sufficient to nearly eliminate TRPM4 currents.  
 
9-Phenanthrol Does not Block BKCa, Kv, or KIR Channels in Smooth Muscle Cells 
 To further examine the utility of 9-phenathrol for investigations into the role of 
TRPM4 channels in freshly-isolated vascular smooth muscle, we examined the effects 
of the compound on the major K+ (BKCa, KV, and KIR) channels involved in the function 
of these cells. STOCs were recorded from smooth muscle cells using the perforated 
patch voltage clamp configuration. 9-phenanthrol (30 µM) had no effect on STOC 
frequency or amplitude (Figure  4.3A, B, and C), demonstrating that the compound does 
not alter BKCa channel activity or the ryanodine receptor-dependent SR Ca
2+ release 
events (Ca2+ sparks) that generate STOCs.  
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The conventional whole cell patch clamp configuration was used to examine the 
effects of 9-phenanthrol (30 µM) on Kv and KIR channel activity. Kv currents evoked by 
voltage steps did not differ between control and 9-phenanthrol treated cells (Figure  
4.3D and E), indicating that the compound is without effect on these channels. KIR 
channels were isolated using BaCl2, according to a method described by Smith et al. 
(172). Ba2+-sensitive currents did not differ when recorded in the presence or absence 
of 9-phenanthrol (30 µM), demonstrating that the compound does not alter the activity of 
KIR channels (Figure  4.3F-H).  
  
Voltage-Dependent Ca2+ Channels are not Blocked by 9-Phenanthrol  
VDCCs are the major Ca2+ influx pathway in cerebral artery myocytes. 
Conventional whole-cell patch clamp was used to investigate the effects of 9-
phenanthrol on VDCC activity in native cerebral artery smooth muscle cells. To evoke 
VDCC currents, cells were voltage clamped at -70 mV and then stepped to +30 mV. 
Whole cell Ca2+ currents recorded (ICa) under these conditions did not differ between 
vehicle and 9-phenanthrol (30 µM) treated cells (Figure  4.4A and B), demonstrating 
that the compound is without effect on VDCCs at this concentration. 
 
9-Phenanthrol Hyperpolarizes Vascular Smooth Muscle Cells 
Knockdown of TRPM4 expression diminishes pressure-induced smooth muscle 
depolarization (42), but the acute effects of TRPM4 inhibition on resting membrane 
potential have not been reported. 9-phenanthrol was used to examine the contribution 
of TRPM4-dependent current to the resting membrane potential of vascular smooth 
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muscle cells in isolated cerebral and cerebellar arteries. Arteries were pressurized to 
physiological levels (70 mmHg) and smooth muscle membrane potential was measured 
using intracellular microelectrodes before and after 9-phenanthrol (30 µM) was 
administered via the superfusion bath, and again after the drug was washed out of the 
recording chamber. Prior to 9-phenanthrol administration, the resting membrane 
potential of arterial myocytes was -39.0 ± 1.9 mV (n=4) (Figure  4.5A and B). In the 
presence of 9-phenanthrol, the membrane potential was significantly hyperpolarized (-
73.1 ± 8.3 mV; n=4) (Figure  4.5A and B). Following washout of the drug, resting 
membrane potential did not differ from that recorded prior to 9-phenanthrol 
administration (-36.4 ± 1.2 mV; n=3), demonstrating that the effects of the drug are 
reversible (Figure  4.5A and B). In theory, 9-phenanthrol-induced membrane 
hyperpolarization could result from inhibition of an inward cation current or from 
activation of an outward K+ current. However, we find that 9-phenanthrol does not alter 
K+ currents in smooth muscle cells, indicating that the compound hyperpolarizes the 
membrane by blocking an inward cation current.  9-phenanthrol does not block TRPC6 
or TRPC3 currents at this concentration, suggesting that a block of a TRPM4-
dependent Na+ current is responsible for hyperpolarization of the smooth muscle 
membrane. These data demonstrate that TRPM4 is an important depolarizing influence 
in cerebral artery smooth muscle cells. 
 
9-Phenanthrol Dilates Pressurized Cerebral Arteries  
 9-phenanthrol blocks TRPM4 currents and hyperpolarizes vascular smooth 
muscle cells in pressurized cerebral arteries. Hyperpolarization of the arterial myocyte 
95 
 
membrane causes vasodilation by closing VDCCs and decreasing intracellular [Ca2+]. 
To determine the effects of 9-phenanthrol on smooth muscle contractility, isolated 
cerebral arteries were pressurized to 70 mmHg and allowed to develop spontaneous 
myogenic tone. Luminal diameter was continuously recorded as 9-phenanthrol was 
added to the superfusion bath. Administration of 9-phenanthrol (30 µM) significantly 
dilated pressurized cerebral arteries (Figure  4.6A-C). Myogenic tone decreased by 
approximately 75% in the presence of 30 µM 9-phenanthrol and was essentially 
eliminated by a concentration of 100 µM (Figure  4.6A-C). The effects of the drug were 
reversible and myogenic tone redeveloped after 9-phenanthrol was washed from the 
superfusion bath (Figure  4.6A and B). The IC50 for 9-phenanthrol-induced dilation of 
cerebral arteries with myogenic tone is 2.6 µM (Figure  4.6C), comparable with the IC50 
of this compound for block of sustained TRPM4 currents in smooth muscle cells (10.6 
µM) (Figure  4.1B).   
We also found that administration of 9-phenanthrol (30 µM) did not alter 
vasoconstriction in response to elevated levels of extracellular KCl (60 mM) (Figure  
4.6D). This finding provides further evidence that the compound does not block 
depolarization-induced Ca2+ influx. Furthermore, these data suggest that 9-phenanthrol 
does not interfere with membrane depolarization resulting from diminished K+ efflux or 
directly inhibit smooth muscle contraction in isolated resistance arteries. Our findings 
indicate that 9-phenanthrol causes arterial dilation by blocking depolarizing TRPM4 
currents to hyperpolarize smooth muscle cell membrane potential and decrease 




 The current study examined the specificity of the TRPM4 blocker 9-phenanthrol 
and investigated the effects of the compound on the resting membrane potential and 
contractility of cerebral artery smooth muscle cells. The major findings of this study are: 
1) 9-phenanthrol inhibits sustained TRPM4 currents in cerebral artery vascular smooth 
muscle cells; 2) At a concentration that nearly abolishes sustained TRPM4 currents, 9-
phenanthrol does not alter the activity of TRPC3, TRPC6 Kv, BKCa, KIR, or VDCC 
channels; 3) 9-phenanthrol reversibly hyperpolarizes the smooth muscle cell membrane 
potential in pressurized cerebral arteries; and 4) 9-phenanthrol reversibly dilates 
cerebral arteries with myogenic tone. These findings demonstrate for the first time that 
9-phenanthrol blocks native TRPM4 channels in cerebral artery myocytes without 
affecting the activity of other channels that are important for smooth muscle function. 
More importantly, these findings show that TRPM4-dependent cation currents are a 
primary depolarizing influence in cerebral artery smooth muscle cells under 
physiological conditions and are critical for establishment and maintenance of myogenic 
tone.  
Selective pharmacological inhibitors are invaluable tools for elucidating the 
functional impact of the many ion channels present in vascular smooth muscle cells. 
Few TRP channels inhibitors with significant specificity are currently available and 
studies of these channels have relied on molecular techniques, such as antisense (40, 
43) or siRNA-mediated (54) downregulation of channel expression. Although these 
methods are useful, limitations, such as phenotypic changes during culture and possible 
off-target effects of the inhibitory molecules complicate interpretation of the data. It is 
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also impossible to examine the acute effects and reversibility of channel inhibition using 
these methods. Antisense-mediated downregulation experiments suggest that TRPM4 
is an important mediator of pressure-(42) and protein kinase C-dependent (41) 
vasoconstriction and autoregulation of cerebral blood flow in vivo (151). To better 
understand the significance of this channel, we sought a pharmacological inhibitor that 
was without significant off-target effects. Prior studies demonstrate that 9-phenanthrol 
effectively blocks TRPM4 under whole-cell (60), inside out (60), and amphotericin B 
perforated patch configurations (54). Grand et al. also report that 9-phenanthrol does 
not affect the function of the CFTR Cl- transporter or TRPM5 channels (60). However, 
the effects the compound on cation, K+, and Ca2+ channels that are important regulators 
of smooth muscle cell membrane potential and contractility have not been previously 
reported. Current findings demonstrate that 9-phenanthrol does not inhibit TRPC3 or 
TRPC6 channels at a concentration (30 µM) that essentially abolishes TRPM4 currents 
in smooth muscle cells. Furthermore, this concentration of the compound does not alter 
STOC activity in cerebral myocytes, demonstrating that 9-phenanthrol is without effect 
on BKCa channels and Ca
2+ sparks generated by release of Ca2+ from ryanodine 
receptors on the SR. We also find that 9-phenanthrol does not alter the activity of Kv or 
KIR currents.  Our findings also show that 9-phenanthrol does not block VDCC activity. 
These data are in agreement with the lack of effect of the compound on arterial 
constriction in response to elevated extracellular K+, demonstrating that the compound 
does not interfere with voltage-dependent Ca2+ influx in intact arteries. In addition, this 
experiment shows that 9-phenanthrol does not interfere with myosin light chain kinase 
activity or other components of the vascular smooth muscle contractile apparatus. 
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Taken together, these findings demonstrate that 9-phenanthrol is a useful reagent for 
studying TRPM4 function in cerebral artery smooth muscle cells. 
Contractility of arterial smooth muscle is largely regulated by graded changes in 
smooth muscle cell membrane potential (85). Membrane depolarization activates 
VDCCs, stimulating Ca2+ influx and enhancing contractility by increasing the activity of 
myosin light chain kinase (85). The resting membrane potential of cerebral artery 
smooth muscle cells (~-40 mV) under physiological levels of intraluminal pressure (~70 
mmHg) (85) is depolarized compared to the K+ equilibrium potential  (~-90 mV) and is 
hyperpolarized compared with the equilibrium potentials for cations (ENa at 37ºC ≈ +60 
mV, ECa2+ ≈ +150 mV) and Cl
- (-30 mV) (121). Thus, cerebral arterial membrane 
potential and contractility are ultimately determined by the relative magnitudes of 
hyperpolarizing and depolarizing currents. Increases in outward K+ currents via BKCa, 
KV, and KIR channels hyperpolarize the smooth muscle plasma membrane and cause 
arterial relaxation (121). Cl- efflux could theoretically have a depolarizing effect on the 
arterial myocyte plasma membrane, but there is no convincing evidence demonstrating 
that Cl- currents are significant for pressure-dependent regulation of cerebral artery 
smooth muscle membrane potential or arterial tone. Furthermore, Ca2+-activated Cl- 
channels are not present in cerebral artery smooth muscle (192), and swelling-activated 
mechanosensitive currents in these cells are dependent on cation channel activity 
(193).  In contrast, significant evidence suggests that TRPC3, TRPC6, and TRPM4 
cation currents contribute to agonist and pressure-induced membrane potential 
depolarization and constriction of cerebral arteries (39, 151, 152, 194).  In the presence 
of 9-phenanthrol, smooth muscle membrane potential in pressurized cerebral arteries is 
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significantly hyperpolarized and myogenic tone is nearly abolished. 9-phenanthrol does 
not activate K+ currents or inhibit TRPC3, TRPC6, or VDCC channels, suggesting that 
membrane hyperpolarization and loss of myogenic tone resulting from 9-phenanthrol 
administration is due to inhibition of TRPM4 cation currents. Treatment with 9-
phenanthrol (30 µM) hyperpolarized smooth muscle cells in cerebral arteries 
pressurized to 70 mmHg to ~-70 mV, whereas, following antisense-mediated 
downregulation of TRPM4, smooth muscle cell membrane potential in cerebral arteries 
pressurized to 80 mmHg expression was ~-50 mV (42).  Differences in membrane 
potential between arteries exposed to TRPM4 antisense and 9-phenanthrol may be due 
to incomplete knockdown in antisense-treated arteries. Previous work from our lab 
using reversible permeabilization suggests that ~80% of smooth muscle cells take up 
TRPM4 siRNA(55), and the cells that do not take up TRPM4 siRNA exhibit normal 
levels of TRPM4 expression (55).  Taken together, these findings indicate that TRPM4 
currents are a major depolarizing influence in cerebral artery smooth muscle cells and 
likely influence contractility by increasing Ca2+ influx via VDCC.  It is also possible that 
TRPM4-mediated Na+ influx could decrease Ca2+ efflux by the Na+/Ca2+ exchanger, 
increasing intracellular [Ca2+] and force generation. In either case, our findings 
demonstrate that TRPM4 channels significantly influence myocyte contractility and 
arterial tone. 
TRPM4 and TRPC6 have been linked to pressure-dependent smooth muscle 
membrane depolarization and myogenic vasoconstriction of cerebral arteries (43, 194). 
The current findings shed light on the relative importance of these channels in this 
important physiological response (9). We find that a concentration of 9-phenanthrol (30 
100 
 
µM) that inhibits ~75% of TRPM4 activity under perforated patch clamp conditions but 
does not block TRPC6 activity, considerably hyperpolarizes the smooth muscle cell 
membrane and nearly abolishes myogenic tone. These data suggest that TRPM4 is the 
primary mediator of pressure-induced responses in cerebral artery smooth muscle cells 
and that TRPC6 channels play a secondary or regulatory role. It is possible that TRPC6 
channels could act upstream of TRPM4 to mediate myogenic constriction by influencing 
intracellular Ca2+ dynamics. TRPM4 requires high levels of intracellular Ca2+ for 
activation (95, 124). We recently reported that in native cerebral artery smooth muscle 
cells, TRPM4 channels are activated by release of Ca2+ from SR stores through IP3 
receptors (54). TRPC6 is permeable to Ca2+, and it is possible that Ca2+ influx through 
the channel could potentiate IP3-dependent Ca
2+ signals required for TRPM4 activity 
(54) by a Ca2+ induced-Ca2+ release mechanism. Interestingly, TRPC6 channels may be 
inherently mechanosensitive (173) and could be directly activated by increases in 
intraluminal pressure. However, a report from another lab did not find TRPC6 channels 
to be mechanosensitive (59), and further experiments are required to test this 
hypothesis and clarify the role of TRPC6 in the development of myogenic tone. While 
the involvement of TRPC6 remains uncertain, the findings of the current study clearly 
demonstrate that TRPM4 channels are required for the maintenance as well as the 
development of myogenic tone. The prior work using antisense oligonucleotides to 
silence TRPM4 prevented the development of myogenic tone and autoregulation of 
cerebral blood flow (42, 151), but because of the limitations of the molecular approach, 
did not investigate the role of the channel in maintaining arterial tone. The current 
findings show that 9-phenanthrol reverses spontaneous myogenic tone when applied to 
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pressurized arteries and that tone redevelops when the drug is removed. Thus, we 
conclude that TRPM4 activity is required for both the development and maintenance of 
myogenic tone in cerebral arteries and is a central regulator of vascular function. 
In summary, our findings demonstrate that 9-phenanthrol is useful for 
investigating the functional significance of TRPM4 channels in vascular smooth muscle 
cells. Using this compound, we find that TRPM4 is a major depolarizing influence 
regulating smooth muscle cell membrane potential and that activity of the channel is 
necessary for the development and maintenance of myogenic tone. Our findings may 
stimulate the development of new therapeutic strategies for the treatment of 
cardiovascular diseases, such as systemic and pulmonary hypertension, that are 
associated with smooth muscle cell membrane depolarization. It is possible that 
derivatives of 9-phenanthrol or other selective TRPM4 inhibitors may reverse this effect 





Figure 4.1: 9-Phenanthrol Inhibits Sustained TRPM4 Currents in Native Cerebral 
Artery Smooth Muscle Cells. A: representative recording of sustained transient 
inward cation current (TICC) activity in cerebral artery myocytes during administration 
of 9-phenanthrol (30 μM). C, closed state. B: dose response of 9-phenanthrol-
mediated inhibition of TICC open channel probability (NPo) (IC50 = 10.6 μM); n = 3–5 





Figure 4.2: TRPC3 and TRPC6 Currents are Not Blocked by 9-phenanthrol. A: 
current (I) vs. voltage (V) relationship of baseline and angiotensin II (ANG II)-induced 
currents in human embyronic kidney (HEK) cells overexpressing TRPC3 recorded in 
absence and presence of 9-phenanthrol (9-phen; 30 μM). Note that the current 
recorded in the presence of 9-phenanthrol is obscured by the current recorded in the 
presence of vehicle. B: summary data of average current density at +85 mV before 
and following ANG II (10 nM) stimulation and after administration of 9-phenanthrol 
(30 μM) in the presence of ANG II; n = 4. C: I vs. Vrelationship of whole cell currents 
recorded from nontransfected HEK cells and TRPC6-expressing cells in absence and 
presence of 9-phenanthrol (30 μM). D: summary data of average current density at 
+85 mV for nontransfected cells and TRPC6-expressing cells in absence and 





Figure 4.3: K+ Currents in Cerebral Artery Smooth Muscle Cells are Not Altered by 9-
phenanthrol. A: representative spontaneous transient outward current (STOC) activity 
following administration of 9-phenanthrol (30 μM). B and C: STOC frequency (f; in 
Hz; B) and amplitude (pA; C) in presence and absence of 9-phenanthrol;n = 6. D: 
representative voltage-dependent K+ (KV) currents in absence and presence of 9-
phenanthrol (30 μM). E: summary of mean current density (pA/pF) vs. voltage 
relationship of KV currents in vascular smooth muscle cells in absence and presence 
of 9-phenanthrol (30 μM); n = 5. F and G: representative inwardly rectifying K+ (KIR) 
currents in absence and presence of 9-phenanthrol (30 μM). H: summary of mean 
current density (pA/pF) at −80 mV for KIR currents in vascular smooth muscle cells in 






Figure 4.4: 9-Phenanthrol Does Not Inhibit Voltage-dependent Ca2+ Currents (ICa) in 
Cerebral Arterial Smooth Muscle Cells. A: representative voltage-dependent ICa  at 
+30 mV recorded from cerebral arterial smooth muscle cells before (left) and after 
(right) administration of 9-phenanthrol (30 μM).B: summary of ICa current densities 




  Figure 4.5: 9-Phenanthrol Hyperpolarizes Vascular Smooth Muscle Cells in 
Pressurized Cerebral Arteries. A: representative recordings of smooth muscle cell 
membrane potential in cerebral arteries pressurized to 70 mmHg under control 
conditions, following administration of 9-phenanthrol (30 μM), and after the 
compound was washed out of the superfusion bath. B: summary data showing the 
effects of 9-phenanthrol on smooth muscle cell membrane potential; n = 4 for control 





  Figure 4.6: 9-Phenanthrol Dilates Pressurized Cerebral Arteries. A: representative 
recoding of luminal diameter of a cerebral artery pressurized to 70 mmHg 
demonstrating the reversible effects of 9-phenanthrol (30 μM) on myogenic tone. B: 
summary data of myogenic tone for pressurized cerebral arteries (70 mmHg) under 
control conditions, following treatment with 9-phenanthrol (30 μM), and after the 
compound was washed out of the superfusion bath; n = 4. C: concentration response 
curve for the effects of 9-phenanthrol on cerebral artery myogenic tone. IC50 = 2.6 
μM; n = 4–7 arteries at each concentration. D: summary data showing the effects of 
9-phenanthrol on KCl (60 mM)-induced constriction of cerebral arteries; n = 4. *P ≤ 





Summary and Perspective 
 
TRPM4 IN CEREBRAL ARTERY SMOOTH MUSCLE CELLS 
TRPM4 channels are present and functionally critical for the regulation of 
cerebral artery tone (43).  Inside-out patch clamp recordings from freshly isolated 
cerebral artery smooth muscle cells in symmetrical cation solutions demonstrate a 
monovalent cation-selective and Ca2+-dependent (EC50 = 200 µM) current with unitary 
conductance suggestive for TRPM4 (~24 pS) (43).  Single channel activity exhibited a 
linear voltage dependency, with inward currents at negative potentials, reversal at 0 mV, 
and outward currents at positive potentials (43).  Ion substitution experiments revealed 
the channel to be selective for Na+ ions (43), and suppression of TRPM4 expression via 
antisense technology decreased channel activity, establishing the molecular identity of 
these currents as TRPM4 (43).  Downregulation of TRPM4 impaired smooth muscle 
depolarization and myogenic constriction of isolated cerebral arteries (43). In addition, in 
vivo knockdown of TRPM4 expression impaired autoregulation of cerebral blood flow in 
living animals (151).  Following suppression of the channel by infusion of antisense 
oligodeoxynucleotides targeting TRPM4 into rat cerebral spinal fluid, blood flow was 
recorded to be higher at resting and elevated mean arterial pressures (151). These 
were the first findings to demonstrate the functional significance of TRPM4 as a major 
contributor to cerebral blood flow regulation. The channel blocker 9-phenanthrol was 
employed to further and more acutely examine the role of TRPM4 in cerebral arteries. 
Blocking of TRPM4 currents with 9-phenanthrol reversibly hyperpolarizes smooth 
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muscle cells leading to dilation of cerebral arteries (58).  Consistent with these findings, 
9-phenanthrol was used to pharmacologically identify TRPM4 as the major contributor 
to resting membrane potential in human and monkey colonic smooth muscle cells (34). 
These findings demonstrate the functional significance of TRPM4 channels in the 
regulation of smooth muscle cell membrane potential.  
In contrast with the findings discussed above, recent studies using TRPM4 
knockout (TRPM4-/-) mice reported no difference in myogenic tone in arteries from 
mouse hind limbs (101). One explanation is that the relationship between membrane 
potential and myogenic tone can vary between arteries of different vascular beds. In 
cerebral arteries, vascular tone as a function of membrane potential exhibits a near 
linear relationship (85), while in skeletal muscle arterioles this relationship is reported to 
be sigmoidal or non-linear (89). This difference between arteries of two vascular beds 
may suggest variations in the mechanism that regulate arterial tone.  Alternatively, 
compensatory mechanisms may exist within knockout mouse systems. For example, 
TRPC6 deficient (TRPC6-/-) mice exhibited a higher mean arterial blood pressure 
compared to controls, but this was associated with an upregulation of TRPC3 channels 
(31). Changes in expression levels of other TRP channels in TRPM4-/- mice were not 
reported, so possible compensation by other channels cannot be ruled out. Further 
experiments are warranted to resolve these issues.  
Elucidation of cellular pathways that regulate TRPM4 channels in cerebral artery 
smooth muscle cells have been hampered by the channel’s intrinsic and rapid Ca2+-
dependent inactivation (43, 57, 95).  Micromolar concentrations of Ca2+ traditionally 
have been included in the recording pipette to activate TRPM4 channels following 
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cellular dialysis under conventional whole-cell recording conditions. Within a few 
minutes following exposure to high Ca2+, TRPM4 activity rapidly inactivates (95, 128).  
Block of PLC activity or including PIP2 in the recording pipette solution can rescue the 
channel from inactivation (125, 202). These observations suggest that loss of channel 
activity could be an artifact of conventional whole cell recording conditions. High 
intracellular concentrations of Ca2+ maintained following dialysis may over-stimulate 
Ca2+-dependent PLC isoforms leading to depletion of local PIP2 stores.  To test this 
possibility, an amphotericin B perforated patch-clamp configuration was employed in 
which whole cell currents were recorded with minimal disruption of subcellular Ca2+ 
signaling pathways (71).  This patch-clamp method allowed novel sustained inward 
cation currents to be recorded from native cerebral artery smooth muscle cells for as 
long as seal viability could be maintained (> 30 min). These currents are referred to as 
“transient inward cation currents” (TICCs) (55).  TICCs have an apparent single channel 
conductance of ~25 pS, reverse near 0 mV in symmetrical cation solutions, and channel 
activity is lost following substitution of extracellular Na+ with impermeant cation NMDG 
(55).  TICC activity was inhibited by TRPM4-blockers flufenamic acid and 9-
phenanthrol, and is attenuated by siRNA-mediated downregulation of TRPM4 
expression in cerebral artery myocytes (55).  These findings demonstrate that the 
molecular identity of the channel responsible for TICC activity is TRPM4. Recording of 
sustained TRPM4 currents under the perforated patch-clamp technique provides a 
novel method for further characterization of channel activity under near-physiological 




REGULATION OF TRPM4 IN CEREBRAL ARTERY SMOOTH MUSCLE CELLS 
The ability to record sustained channel activity from native cells without major 
disruption of intracellular Ca2+ dynamics has allowed TRPM4 channel regulation to be 
characterized. TRPM4 requires [Ca2+] above resting cystolic levels for activation.  In 
freshly isolated cerebral artery smooth muscle cells, removal of extracellular Ca2+ did 
not acutely affect TRPM4 channel activity (55, 57). Blocking of the sarco(endo)plasmic 
reticulum Ca2+-ATPase (SERCA) rapidly inhibited TICC activity, suggesting that Ca2+ 
released from internal stores activated the channel (55, 57).  Inhibition of inositol 
trisphosphate receptors (IP3R), but not ryanodine receptors, diminished TICC activity, 
suggesting that TRPM4 channels are activated by Ca2+ released from the sarcoplasmic 
reticulum (SR) via IP3R (55, 57). In agreement with these findings, the membrane 
permeable inositol trisphosphate (IP3) analog Bt-IP3 increased TICC activity (57).  This 
effect was lost when cells were pretreated with the IP3R blocker xestospongin C (57), 
providing further evidence to the involvement of IP3R in the activation of TRPM4 
channels. The coupling between TRPM4 and IP3R was also reported for the neonatal 
mouse preBötzinger complex, where the channels contribute to neuronal control of 
respiratory rhythms (24). These data suggest that a Ca2+ release event culminating from 
IP3R within in the SR membrane activates TRPM4 channels located in the plasma 
membrane.    
Changes in cytosolic Ca2+ dynamics influence IP3R-dependent activation of 
TRPM4.  Using immunocytochemistry and membrane specific staining, IP3Rs in the SR 
membrane and TRPM4 channels located on the plasma membrane were found to be 
proximal (57). These findings were complemented by conventional whole cell patch 
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clamp experiments where the Ca2+ buffers ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA) or bis-ethane-N,N,N′,N′-tetraacetic acid (BAPTA) 
were included in the pipette solution and dialyzed into the cell under the whole cell 
configuration. BAPTA and EGTA have identical steady-state kinetics and Ca2+ binding 
affinities, but significantly differ in their binding rate constants (5).  BAPTA can bind free 
Ca2+ at a rate that is two orders of magnitude faster than EGTA (5).  IP3R-mediated 
activation of TRPM4 was observed when 10 mM EGTA but not 10 mM BAPTA (57) was 
included in the recording pipette. This difference in channel activity by equal 
concentrations of BAPTA or EGTA suggests that the IP3R-mediated activation of 
TRPM4 occurs within spatially restricted domains. Ca2+ microdomains, with a Ca2+ 
source-to-sensor distance of greater than 50 nm, are defined by Ca2+-dependent 
responses that are equally disrupted by identical concentrations of BAPTA and EGTA 
(112).  In contrast, Ca2+ nanodomains, with a Ca2+ source-to-sensor distance less than 
50 nm, are defined by Ca2+-dependent responses that are significantly interfered with by 
BAPTA, but not by equal concentrations of EGTA (112). Therefore, the difference in 
channel activity in the presence of equal concentrations of BAPTA vs. EGTA, suggests 
that TRPM4 channels and IP3Rs are located no more than 50 nm apart within Ca
2+ 
nanodomains (Figure  5.1)  Additionally, loss of TRPM4 channel activity following Ca2+ 
chelation with BAPTA provides electrophysiological evidence that the IP3R-mediated 
activation of TRPM4 channels occurs via a Ca2+ release event and that these signaling 




Ca2+ is an important second messenger for multiple overlapping intracellular 
signaling pathways.  TRPM4 channels are activated by micromolar levels of cytosolic 
Ca2+, and recent work suggests that localized and transient release of Ca2+ from 
intracellular stores through IP3R activates TRPM4 channels.  IP3Rs are also influenced 
by intracellular Ca2+, but at much lower concentrations and exhibit a biphasic sensitivity 
where Ca2+ activates and inactivates the channel within a nanomolar range (300 nM) 
(73, 74).  Ca2+ can excite or inhibit IP3Rs directly at several distinct Ca
2+ binding sites 
within the channel (for review see (113)) or indirectly by interfering with binding of IP3 to 
the channel (11).  Additionally, binding of IP3 to IP3R increases the Ca
2+ sensitivity of 
channel (98) and the interplay between intracellular Ca2+ and IP3 binding to IP3R 
contributes to the versatility and hierarchical recruitment of observed Ca2+ signaling 
events. In response to increased levels of cytosolic IP3, individual IP3Rs are activated 
giving rise to unitary events (Ca2+ blips) (16, 178), then clusters of IP3Rs open together 
(Ca2+ puff) (150, 178, 182), and ultimately these events propagate from one cluster to 
another (Ca2+ waves) (110) . The particular IP3R-mediated Ca
2+ release event 
physiologically important for activation of TRPM4 in cerebral artery myocytes is still not 
known, but recordings of sustained TRPM4 channel activity from smooth muscle cells 
suggest that PLC-dependent generation of IP3 and intracellular Ca
2+ required for IP3R 
activation are continuously present.  Separation of the IP3R-dependent Ca
2+ release 
event from the Ca2+ signaling pathways initially regulating IP3R function can be 
achieved through the difference of Ca2+ sensitivity between TRPM4 and IP3R. Low 
levels of intracellular Ca2+ can modulate communication between IP3Rs without affecting 
TRPM4 channel activity and smooth muscle membrane depolarization.  Additionally, 
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signaling events initiated distal to SR/plasma membrane junctions can propagate 
between neighboring IP3Rs towards nanodomains where IP3R-dependent activation of 
TRPM4 channels occurs.  These two tiers of Ca2+ sensitivity, with low nanomolar 
concentrations of Ca2+ stimulating IP3Rs and higher micromolar concentrations 
activating TRPM4 channels, provides a separation and prevention of crosstalk between 
Ca2+ signaling events.  This arrangement allows for multiple localized Ca2+ events to 
occur concurrently without stimulating TRPM4-mediated membrane depolarization and 
myogenic constriction. 
In addition to TRPM4, other receptor-dependent and mechanosensitive TRP 
channels have been shown to play important roles in smooth muscle contractility, but 
the molecular mechanisms of how these channels may interact has yet to be 
addressed. IP3Rs require on the presence of IP3 and Ca
2+ for activation, therefore IP3R-
mediated stimulation of TRPM4 depends on an initial source of localized Ca2+. We 
propose that Ca2+ permeable TRP channels form upstream signaling complexes with 
IP3R and TRPM4, whereas Ca
2+ influx through these channels can stimulate IP3R, 
leading to Ca2+-induced Ca2+-release dependent activation of TRPM4. Members of the 
TRPC, TRPM, and TRPV subfamilies have been reported to modulate receptor-
activated calcium entry.  Angiotensin II, a potent circulating vasoconstrictor, increases 
channel activity of TRPC1 and TRPC6 channels in rabbit mesenteric myocytes (48, 
163). Additionally, TRPC6 currents also increase following exposure to phenylephrine 
(76), vasopressin (83), and reactive oxygen species (ROS) productions (32).  In 
vascular smooth muscle cells, TRPC3 is activated by ET-1 (141) and UTP (152), with 
the latter causing membrane depolarization and vasoconstriction in cerebral arteries. 
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Activation of these agonist-sensitive TRP channels may lead to Ca2+ influx, stimulation 
of IP3R, and activation of TRPM4 channels. Additionally, several TRP channels 
expressed in the vasculature, including TRPV4, TRPC1, 5, 6, TRPM4, 7, TRPA1, and 
TRPP2 (for review see (75)) are reported to have indirect or direct mechanosensitive 
currents, but their physiological relevance is still highly debated.  Similar to the 
proposed upstream signaling of agonist-sensitive TRP channels, mechanosensitive 
TRP channels may be localized within signaling domains and allow for the indirect 
stretch-sensitive activation of TRPM4. Ca2+-induced Ca2+-release dependent signaling 
complexes have been previously reported in cerebral arterial myocytes, where Ca2+ 
conductance via TRPV4 channels contribute to smooth muscle hyperpolarization and 
arterial dilation (37). In response to endothelium-derived arachidonic acid metabolite 11, 
12 epoxyeicosatrienoic acid (11, 12 EET), TRPV4-like currents are activated in 
mesenteric smooth muscle cells isolated from wild type but not from TRPV4 deficient 
mice (37).  Ca2+ influx through TRPV4 leads to membrane hyperpolarization and arterial 
dilation through the formation of Ca2+ signaling complex with ryanodine receptors and 
BKCa channels.  Ca
2+ entry through TRPV4 stimulates ryanodine receptors in the SR 
membrane, which generates Ca2+ sparks, activates proximal BKCa channels, and leads 
to membrane hyperpolarization (37).  The presence of these hyperpolarizing and 
depolarizing signaling complexes may act to amplify and integrate multiple TRP channel 
inputs of different external stimuli leading to modulations in smooth muscle membrane 
excitability and vasoconstrictor response.    
Generation of myogenic tone requires PLC activity (136), but the mechanism 
behind PLC-dependent membrane depolarization and myocyte contraction is still not 
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clear.  Recent findings showing that TRPM4-mediated membrane depolarization 
requires Ca2+ released from IP3Rs in the SR which may provide insight to PLC-
dependent vasoconstriction.  Production of the endogenous IP3R activator IP3 occurs 
through the hydrolysis of PIP2 by PLC, and, in arterial smooth muscle cells, the 
intracellular concentration of IP3 (114) and PLC activity (136) are positively correlated 
with changes in arterial intraluminal pressure.  Additionally, pharmacological inhibition of 
PLC results in smooth muscle membrane hyperpolarization and disruption of sustained 
pressure-induced constriction of arteries (82, 136).  Therefore, tonic PLC activity could 
generate intracelluar IP3 levels required for IP3R activation and TRPM4-mediated 
smooth muscle membrane depolarization and maintenance of cerebral vascular tone. 
Multiple isoforms belonging to three families (β, γ, and δ) of PLC have been detected in 
vascular smooth muscle cells (97).  Extracellular agonists bind to G protein-coupled 
receptors located on the plasma membrane and may activate PLCβ isoforms leading to 
receptor-mediated vasoconstriction.  Early reports observed complete elimination of 
pressure- and agonist-induced tone following the inhibition of tyrosine kinases, 
upstream activators of PLCγ isoforms (30, 136). The direct influence of PLCβ or PLCγ 
isoforms on TRPM4 channel activity has not been shown, but generation of IP3 and 
activation of sustained IP3R-mediated TRPM4 currents could provide the depolarizing 
stimulus for PLC-dependent contractions. In addition, PLC has several upstream and 
downstream effects, expanding the possible interactions and molecular pathways that 




PKC plays an important role in regulating basal arterial tone in cerebral arteries 
(41, 81, 156). Stimulation of PKC activity increases the Ca2+-sensitive activation of 
TRPM4 currents (131), and in cerebral artery myocytes PMA elicits TRPM4-dependent 
membrane depolarization and arterial constriction (41).  To further elucidate the 
mechanism of PKC-dependent increases in cation current, cell surface biotinylation and 
TIRF microscopy were used to examine the expression of TRPM4 protein in the plasma 
membrane (23).  Following PKC stimulation, TRPM4 channels rapidly translocated (~5 
minutes) to the plasma membrane in A7r5 cells, primary cerebral artery myocytes, and 
intact arteries (23).  This effect was lost following selective inhibition of PKCδ, but not 
following blocking of PKCα and PKCβ (23).  RNAi-mediated downregulation or 
pharmacological inhibition of PKCδ caused TRPM4 channels to translocate from the 
plasma membrane into the cytosol (52), suggesting that tonic PKCδ activity is required 
to maintain surface expression of TRPM4. Channel activity was inhibited following the 
administration of the PKCδ blocker rottlerin (52), and suppression of PKCδ expression 
hyperpolarized smooth muscle cells and impaired vessel constriction in response to 
both PMA and increases in intraluminal pressure in intact cerebral arteries (23). These 
findings provide a novel mechanism for the regulation of smooth muscle excitability 
through the dynamic trafficking of TRPM4 channels to and from the plasma membrane, 
and indicate that PKC-dependent increases in Ca2+ sensitivity of the channel may result 
from elevated levels of TRPM4 protein at the cell surface. 
BKCa channels are a major hyperpolarizing influence in smooth muscle cells and 
recent evidence from our lab demonstrate that TRPM4 is a major depolarizing influence; 
therefore the resting membrane potential of smooth muscle cells is dependent on the 
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counteracting yet complimentary interactions of these two channels. The involvement of 
smooth muscle BKCa channels in the control of endothelial-dependent arterial tone has 
been well documented, but the participation of TRPM4 is still not known. Vasorelaxtion 
of many vascular beds in response to nitric oxide (NO) involves the activation of BKCa 
channels (51, 196). NO can stimulate guanylyl cyclase, elevate cyclic guanosine 
monophosphate (cGMP) levels, and activate cGMP-dependent protein kinase (PKG) 
(157).  Additionally, beta-adrenergic stimulation of Gs-coupled proteins activate adenylyl 
cyclase and increase cyclic adenosine monophosphate (cAMP), resulting in the 
stimulation of cAMP-dependent protein kinase (PKA) (91, 169) . PKG and PKA activity 
mediates relaxation of many types of smooth muscle cells, in part, through the 
activation of BKCa channels, initiation of membrane hyperpolarization, and closing of L-
type Ca2+ channels (92).  As of now, there is no evidence of the physiological effect of 
NO, cGMP, cAMP, PKG, or PKA on TRPM4 channel currents, but the effect of these 
pathways on IP3R has been well studied. PKG- and PKA-dependent phosphorylation of 
IP3R via an IP3R-associated cGMP kinase substrate (IRAG) greatly attenuates channel 
function by directly regulating IP3 sensitivity and indirectly by regulating IP3 generation 
(111, 167).  PKC/IRAG inhibition of IP3R-dependent Ca
2+ release relaxed colonic and 
aortic smooth muscle cells (111, 166). In tracheal smooth muscle cells, PKA activity 
attenuated IP3R-mediated Ca
2+ release by inhibiting the generation of IP3 and reducing 
the number possible IP3 binding sites (88).  Inhibition of IP3R-mediated Ca
2+ release by 
PKG or PKA activity may result in a loss of TRPM4 channel activity. The possible 
negative effect of PKA and PKG on TRPM4-mediated membrane depolarization 
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compliments the positive effect they have on BKCa channel activity, ultimately leading to 
membrane hyperpolarization and relaxation of arteries.    
 
TRPM4 IN HYPERTENSION 
Smooth muscle hyperexcitability leading to increased peripheral resistance within 
the microvasculature contributes to the development of essential hypertension (50).  In 
vascular smooth muscle cells, the regulation and permeability of K+ and Ca2+ are 
altered during this disease, but involvement of TRPM4 channel activity has not been 
reported.  In many hypertensive human and animal models, elevated vascular tone has 
been reported and is associated with a more depolarized resting membrane potential 
and disrupted Ca2+ handling (190). L-type Ca2+ current density in vascular smooth 
muscle cells from spontaneous hypertensive rats (SHR) is increased compared to their 
normotensive Wistar-Kyoto (WKY) controls (161, 191), leading to an increase in basal 
intracellular Ca2+ concentrations.  In addition, BKCa channel activity is increased under 
hypertensive conditions (45, 160). The open probability of BKCa channels increases at 
more positive potentials, suggesting that increased channel activity during hypertension 
results from amplified depolarizing currents. TRPM4 is an intriguing potential contributor 
to this pathophysiological condition, as several of the molecular pathways that regulate 
its activity have also been shown to be altered under these conditions.  For example, 
PLC activity and the generation of IP3 increase in response to intraluminal pressures 
(114), and basal intracellular IP3 concentrations are elevated in genetically hypertensive 
rats (13, 105, 154, 185, 187, 198).  Although no difference in IP3R expression or IP3R-
mediated Ca2+ release has been reported, an increase in intracellular IP3 level together 
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with elevated cytosolic Ca2+ levels could increase tonic IP3R-mediated TRPM4 channel 
activity and membrane depolarization.  PKC activity has also been linked with pressure-
dependent vasoconstriction and PMA-mediated activation of PKC enhances myogenic 
activity (109). Inhibition of PKC in cerebral arteries has a significantly greater effect on 
myogenic tone in cerebral arteries isolated from SHR rats compared to WKY controls 
(81), suggesting an increase in PKC activity during hypertension. Surface expression of 
TRPM4 channels is dynamically regulated by PKC (23) and the observed increase in 
PKC activity in SHR rats can lead to more channels localized in the plasma membrane.  
Interestingly, a missense mutation of TRPM4 impaired the endocytosis of channels 
leading to elevated channel density at the plasma membrane, contributing to the 
development of progressive familial heart block type 1 in humans (90). Mutations with 
similar effects on TRPM4 distibution in vascular smooth muscle cells could lead to 
higher tonic TRPM4 channel activity, increased membrane depolarization, and 
ultimately contribute to smooth muscle hyperexcitability, thereby contributing to 
hypertension.  Additional studies investigating the involvement of TRPM4 in 
hypertension are needed to test this hypothesis.  
 
CONCLUSION 
The discovery of TRPM4 has unmasked the molecular identity of one type of 
NSCCa channels that were first described in 1981. TRPM4 processes biophysical 
properties and broad distribution reminiscent of NSCCa channels.  In addition, TRPM4 
channels are selective for monovalent cations, activated by, but impermeable to, Ca2+, 
and are regulated by components of the PLC and PKC pathways (Figure  5.3).  
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Advancements in the ability to record TRPM4 channel activity in native smooth muscle 
cells has allowed for further insight to the signaling complexes that regulate the channel.  
It is apparent that TRPM4 is an essential ion channel for cerebral artery myocyte 
depolarization leading to contraction, but additional studies are needed to fully elucidate 
the possible complementary and integrative role it may play with other ion channels 
proposed to influence smooth muscle depolarization. More importantly, the 
pathophysiological role of TRPM4 in vascular dysfunction associated with hypertension, 






Figure 5.1: Simulation of TRPM4 by Ca2+ Nanodomain Created by Ca2+ released 
from the Sarcoplasmic Reticulum via IP3R.  In freshly isolated smooth muscles, 
TRPM4 activation requires Ca2+ released from the SR through proximal IP3R.  The 
Ca2+ concentration profile comparing the buffering capacity of the slow and fast Ca2+ 
chelators EGTA and BAPTA on [Ca2+]i as a function of distance from a single IP3R 
Ca2+ release site. Simulation data using CalC software v. 6.0 (102) was re-plotted 






Figure 5.2: Regulation of TRPM4 Activity in Contractile Cerebral Artery Smooth 
Muscle Cells. PM, plasma membrane; SR, sarcoplasmic reticulum; PKCδ, protein 
kinase C; PIP2, phosphatidylinositol 4, 5-bisphosphate; PLC, phospholipase C; IP3, 
inosital triphosphate; IP3R, inosital triphosphate receptor; VM, membrane potential; 
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